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Title of project 
Waiting to die: Staging of HIV positive people at the first HIV test - Region A, Nelson 
Mandela Metropole (January 1991- April 2000) 
 
Abstract 
This project suggests that HIV people in Region A (Nelson Mandela Metropole, formerly 
Port Elizabeth) health district of the Eastern Cape, seek HIV testing when they are 
already in stages three (late disease) and four (AIDS) of HIV infection.  
This was done by: 
i)   reviewing available literature on the disease progression of HIV-1 subtype C 
ii)  reviewing clinical staging systems developed for patient care as well as case    
     definitions developed for surveillance purposes (1980-2000) 
iii) reviewing the application of these definitions in other African countries (Cote   
     d’Ivoire, Gambia, Uganda and Zambia).  
 
This thesis analysed 27 505 anonymous HIV positive people’s case level data from 
January 1991 to April 2000. The data had been obtained from the AIDS Training 
Information and Counselling Centre (hereafter ATICC) in the Nelson Mandela Metropole 
in 2000. This data included the test date, symptoms and follow-up diagnoses. Further, 
medical symptoms of HIV positive people were staged consistent with the four phases of 
the World Health Organisation’s Clinical Staging System as revised in 1999.  
 
The results of this study support the hypothesis that HIV positive people in Region A 
health district of the Eastern Cape seek HIV testing when they are already in stage three 
(late disease) and stage four (AIDS) of HIV infection. The consequences of diagnoses 
only in the advanced stages of HIV infection will have a devastating impact on case 
management. Therefore, this paper yields important data for South African policy makers 
to write health and welfare policies that might improve the quality of life of those 
terminally infected with HIV. This study seeks also to help encourage much earlier 
testing.  
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Glossary 
 
Acute HIV: can resemble flu, or other viral syndromes. Typical symptoms include fever, 
headache, fatigue, and swollen lymph nodes. People may also experience aching muscles 
and a rash that occurs anywhere on the body and may change locations. These symptoms 
may last from a few days to 4 weeks, and then subside. 
ADI: AIDS defining Illness 
AIDS: Acquired Immuno-deficiency Syndrome  
Antibodies: a special kind of blood protein produced in lymphoid tissue in response to 
the presence of an antigen  
Asymptomatic HIV infection: characterized by the absence of symptoms associated 
with HIV, such as fevers, weight loss, oral thrush, or any opportunistic infections (such as 
with Pneumocystis carinii pneumonia, cytomegalovirus, and Mycobacterium avium). 
ATICC: AIDS Training, Information and Counselling Center  
CD: a numerical system for classifying antigens  
CDC: Centres for Disease Control  
CD4: surface antigen on T-cells that is particularly important for immune resistance to 
viruses 
ETB: Extra pulmonary tuberculosis 
DOH: Department of Health 
HAART: Highly Active Antiretroviral Therapy 
HIV: Human Immuno-deficiency Virus 
HSV: Herpes simplex virus 
ICD10: International Classification for Diseases 10  
NMM: Nelson Mandela Metropole  
PGL: Persistent Generalized Lymphadenopathy, lymph nodes are larger than one            
centimeter in diameter, in two or more other sites other than the groin area for a       
period of at least three months  
 
 
 
 
 xi
Prevalence: the percentage in a group infected at a particular point in time  
PTB: Pulmonary tuberculosis 
Seroconversion:  produce specific antibodies in response to the presence of an antigen 
(e.g. a virus or a vaccine) 
Serology: study of blood and serum the fluid that separates from clotted blood or blood 
plasma 
Seronegative: do not show antibodies for HIV in serum  
Seropositive: show antibodies for HIV in serum  
Serum: the clear liquid that can be separated from clotted blood 
StatsSA: Statistics South Africa 
STI: Sexually transmitted infection  
TB: Tuberculosis 
TLC: total lymphocyte counts 
WHO CSS: World Health Organization Clinical Staging System 
WRCS: Walter Reed Classification System 
Zidovudine: AZT an antiviral drug used in the treatment of AIDS and HIV infection 
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Chapter 1 
Introduction 
 
1.1 Background  
In July 2004, a collaborative study by the Medical Research Council, the Actuarial 
Society of South Africa and the Centre of Actuarial Research at the University of Cape 
Town, estimated the total HIV prevalence rate (the proportion of people who are infected 
with HIV), at 11%. This study suggested that in 2004, 5.02 million people in South 
Africa were living with HIV. Of these, over 4.7 million were in the age group 18 to 64 
years, i.e. the labour force. Among adults aged 15 to 49 years, 4.5 million are living with 
HIV. Also, an estimated 2.5 million woman aged 15 to 49 years, were infected with HIV 
and 1.95 million men in the same age group (Dorrington et al. 2004:14). 
 
A following study by the Department of Health (DOH) in collaboration with UNAIDS, 
estimated that 5.5 million people were living with HIV, in 2005. Among adults 15 to 49 
years old, HIV prevalence was 18.78%. In the same age group, 4.9 million were living 
with HIV, of which 3.12 million were female and 2.19 million males (DOH 2006:17). 
 
Also, in 2005, the Human Science Research Council estimated that HIV prevalence in the 
population two years and older was 10.8%. HIV prevalence was higher in woman, 3.3% 
than in men, 8.2%. Among people aged 15 to 49 years HIV prevalence was 16% (Shisana 
et al. 2005:33-34).  
 
Subsequently, the 2006 UNAIDS Report estimated that in 2005, 5.5 million people in 
South Africa were living with HIV. An estimated 3.1 million, were woman older than 15 
years. Also, HIV prevalence in the age group 15-49 years was 18.8%. HIV prevalence 
among women aged 15 to 24 years was 14.8%, whilst HIV prevalence among men in the 
same age group were 4.4% (UNAIDS 2006:505-506).  
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Also in 2006, Statistics South Africa estimated that 5.2 million people were infected with 
HIV. The estimated total HIV prevalence rate is 10.9%. HIV prevalence among people 
aged 15 to 49 years is 18.2%. The prevalence rate is (20%) highest among women in the 
age group 15 to 49 years old. HIV prevalence among adults aged 20 to 64 years is 17.1% 
(StatsSA 2006:3). 
 
Thus, HIV affects mostly the labour force and people in their reproductive years. Females 
in their reproductive years are more susceptible to HIV, than males. 
 
However, rates about AIDS and mortality in Sub-Saharan Africa, was based on estimates 
and projections. These estimates convey information results mainly on prevalence, 
prevention and the projected demographic impact of HIV/AIDS (Adetunju 1998:17). 
Prior to 1994, there was no systematic collection of mortality data on a national scale in 
South Africa. Therefore, mortality estimates were based on fragmented data, and the 
estimation methods and the quality of the data were largely unclear. Consequently, 
estimates of mortality due to HIV/AIDS in South Africa vary, and often by a large 
number (Udjo 2005: 90). Nevertheless, differences in HIV estimates should not distract 
from the fact that HIV has become South Africa’s biggest health problem of the 21st 
century (Bah 2005:155).  
 
HIV/AIDS impacts on socio-economic and human development in South Africa. AIDS 
will increase the adult mortality rate for all population groups and reduce life expectancy. 
It will alter the age and gender structure of the population because females who are more 
vulnerable to the disease will die more quickly. Moreover, this will impact on population 
growth as females of childbearing age will die (Mostert et al. 1998:97-100, Whiteside 
1998:79; Whiteside & Sunter 2000:70-73; Bartos & Piot 2002:209-210; Ziehl 2002:67-
71; Dorrington et al. 2004: 3). The AIDS pandemic will reduce the average household 
income and increase medical expenses (Mostert et al. 1998:97-100, Whiteside 1998:79; 
Whiteside & Sunter 2000:70-73; Bartos & Piot 2002:209-210; Ziehl 2002:67-71; 
Dorrington et al. 2004:3; Shisana et al. 2005: 111). As workers become ill and children 
are orphaned, HIV/AIDS will create an increasing economic and social burden for the 
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government (Mostert et al. 1998:97-100, Whiteside 1998:79; Whiteside & Sunter 
2000:70-73; Bartos & Piot 2002:209-210; Ziehl 2002:67-71). 
 
However, the governments HAART (highly active antiretroviral therapy) programme as 
reduced the impact of HIV/AIDS on mortality (Dorrington & Johnson 2006:563). 
 
The impact of AIDS on socio-economic and human development creates a need for 
“disease surveillance the ongoing systematic collection, analysis, interpretation, and 
dissemination of data, concerning particular diseases” (De Cock et al. 1991:1185). 
Epidemiological surveillance of AIDS is an important public health tool because it 
monitors the HIV epidemic, estimating disease burdens, planning for necessary social and 
health services, especially in countries where resources and mechanisms for periodic 
surveys of HIV sero-prevalence  (individuals showing antibodies for HIV in their serum) 
are not yet established (Weniger et al. 1992:1213).  
 
Though AIDS is not directly responsible for death, it leaves the body increasingly 
vulnerable to other opportunistic infections.  Therefore, information on the interaction 
between HIV and other causes of death is crucial (Adetunju 1998:17, Pisani 1998:24).  
 
People die of opportunistic infections but not of AIDS. In consequence, studies of the 
incubation period are essential for government to allocate scarce resources to the 
pandemic (Whiteside 1998:79; Doyle et al. 1998:73). Yet, few studies in which the exact 
time the individual was infected with HIV have been carried out in Africa. Such studies 
require documenting the presence and frequency of medical signs as symptoms that occur 
at the time of seroconversion (Mugerwa & Ryder 1994:270). The best way to estimate the 
incubation period is to study current data and experiences “as well as life-time risks of 
various opportunistic infections and cancers from routinely collected patient records and 
cumulative epidemiological literature” (Doyle et al. 1998:73).  
 
Furthermore, Couthino (2000:A22) argues that, identifying factors such as age, ethnicity 
and nutrition, which influence the incubation period, are important for understanding the 
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natural history (i.e. detailed progression from HIV infection to sickness and death) of the 
disease, since predicting the disease progression is useful for deciding the time to start 
antiretroviral therapy. The incubation period is also crucial because most future 
projection requires an in-depth knowledge of this period. 
 
A complicating factor in studies of the incubation period is that the vast majority of 
Africans do not know their HIV status (Marum et al. 2001:527).  This is mainly as result 
of ignorance, stigma, fear of death, and fear of needles. UNAIDS reports that the 
numbers of people who are unaware that they infected with the virus are the highest in 
countries worst affected by the epidemic. Less than 10% of people infected in Sub-
Saharan Africa know that they are infected (De Cock et al. 1991:1; Schoub 1999:236; 
Marum et al. 2001: 527). Such serious under-estimation of AIDS cases may have 
distorted social, economic and medical implications of AIDS in Sub-Saharan Africa 
(Mugerwa & Ryder 1994:270). Consequently, most people infected with HIV in these 
countries are less likely to adopt behaviours that would prevent further transmission. 
They are, also unable to access healthcare services in the early stages of HIV infection 
(Marum et al. 2001:527). 
 
1.2 Problem statement 
The above literature explains the importance of establishing at what stage of the disease 
individuals seek HIV testing. Opportunistic infections are prevalent among people 
suffering from AIDS in South Africa, but who do not know that they are HIV positive. 
This study seeks to shed light on this particular problem by using case level data collected 
from the Nelson Mandela Metropole. 
  
1.3 Aims and objectives  
The project aims to provide more insight into the lack of information concerning the 
clinical stages of HIV positive individuals. This study also reviews the literature relating 
to all current case definitions for AIDS in South Africa. Then, anonymous case level 
patient records from1991-2000 collected from the Region A health district in the Eastern 
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Cape will be analysed. These records comprise 27 505 cases from the AIDS Training 
Information and Counselling Centre (ATICC) in the Nelson Mandela Metropole.  
 
The study would attempt to determine: 
• The diagnostic stage at the time of the HIV test using the World Health Clinical 
Staging System. 
• Determine whether there is any relationship between diagnostic stage and socio-
demographic and community characteristics including, gender population group, 
diagnostic age, area type and year of diagnosis.  
 
1.4 Hypotheses 
The majority of patients in the Nelson Mandela Metropole, i.e. Port Elizabeth as it was 
formerly known, seek HIV-testing when they are already in stages three (late disease) and 
four (AIDS) (see Appendix C). The following null hypotheses will be investigated: 
 
H01: There is no significant difference between males and females with regards to 
the diagnostic stage at the time of the HIV test. 
H02: There is no significant difference between population groups in relation to 
the diagnostic stage. 
H03: No significant difference exists between age groups with regard to the 
diagnostic stage. 
H04: There is no difference regarding the type of dwelling relating to the stage at 
the time of HIV testing. 
H05: No significant difference exists between urban/ rural areas and the diagnostic 
stage. 
H06: The diagnostic institute is not significant in relation to the stage at the time of 
HIV testing  
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1.5 Chapter outline  
Chapter two briefly discusses the literature concerning HIV subtypes, the geographical 
distribution of HIV subtypes and survival after infection. The chapter concentrates on a 
chronological overview of HIV/AIDS case definitions used for clinical purposes as well 
as those used for disease surveillance. The emphasis is on showing how African countries 
have modified the World Organisation Health Clinical Staging System to suit regional 
differences of HIV/AIDS. This is important since local variations of opportunistic 
infections are prevalent in different parts of the world.  Finally, an evaluation of the 
World Health Organisation Clinical Staging System in South Africa is presented.  
 
Chapter three outlines the research design and the methodology used to determine the 
diagnostic stage at the time of the HIV test. In particular how the World Health 
Organisation Clinical Staging System and International Classification for Diseases (ICD 
10) was used in this thesis to infer stages of HIV from diagnostic cases. Further, the 
chapter outlines the study area, states the hypotheses and explains the rationale behind the 
data analysis.  
 
Chapter four presents the results obtained from the AIDS Training Information and 
Counselling Centre (ATICC). The results include the diagnostic stage using the WHO 
Clinical Staging System and the International Classification for Diseases (ICD10). What 
follows after, is a description of the population characteristics of individuals in this study. 
Finally, the relationship between diagnostic stage and age, gender structure and place of 
residence and diagnostic institutions will be examined.  
 
In Chapter five the results obtained from the AIDS Training Information and Counselling 
Centre (ATICC) will be discussed. First, the clinical stage at the time of the HIV test will 
be discussed. Then, the population characteristics of the area will be discussed. The 
relationships between age, gender structure and urban/rural prevalence, diagnostic 
institutions and diagnostic stage will be considered. 
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Chapter six outlines the conclusion. First the results and discussion will be summarized. 
Afterwards, the limitations of the study will be discussed. Finally, the researcher provides 
a policy afterword.  
 
Appendices A – F include HIV/AIDS case definitions developed since 1985. Appendix G 
is the World Health Classification System for Diseases 10 used in Chapter three to 
classify diseases. Appendix H is the revised clinical staging system (see also Chapter 
three), based on the World Health Clinical Staging System. Appendix J is the list of 
tables that includes all tables used to generate graphs in the main text.  
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Chapter 2 
Literature Review 
 
2.1 Introduction 
To develop a diagnostic staging system suitable for the data, this chapter reviews 
literature concerning HIV sub-types and their geographical distribution, as well as the 
incubation period and natural history of the disease. What follows is a chronological 
reassessment of classification systems developed for disease surveillance and clinical 
patient care. Finally, this chapter will discuss the implications of the various World 
Health Clinical Staging Systems for South Africa.  
 
2.2 Definitions of AIDS 
In 1982, AIDS was originally defined by the Centres for Disease Control and Prevention 
(CDC) in Atlanta, USA, for the purpose of surveillance as follows: “the presence of a 
reliably diagnosed “opportunistic” disease and of an underlying defect in cell-mediated 
immunity in the absence of known causes of immune defects such as immunosuppressive 
therapy or malignancies” (Onin 2002:299). HIV as the cause of AIDS was first 
discovered by Luc Montagnier and Robert Gallo at the Pasteur Institute in Paris 1985 
(Montagnier 2002:2). 
 
AIDS is, by definition, the end-stage disease manifestation of an infection by a virus 
called the Human Immunodeficiency Virus (HIV). The virus primarily affects two organ 
systems of the body namely the cells of the immune system and the nervous system. 
Within the immune system there are two main types of cells that are infected by HIV: 
firstly, the lymphocytes, and particularly the T-helper or CD4 lymphocytes; secondly, 
cells called monocytes and macrophages whose function is to rid the body of foreign 
protein by ingesting them and also to present them to the immune system to enable 
immune response against them to prepare against them. The HIV virus can replicate in 
these cells without apparently damaging them and they, thus, act as the major reservoir 
 
 
 
 
 9 
for infectious virus in the body. Another effect of HIV on the immune system is 
lymphadenopathy (the swelling of the lymph nodes) (Schoub 1999:24). 
 
The T-helper (CD4 lymphocytes) regulates the immune system and thus plays a central 
role in the control of the immune function. The significant loss of the T-helper 
lymphocytes of the immune system results in a profound loss of immune function and 
causes immunosuppression. There are several consequences for the body: profound 
weight loss, chronic diarrhoea and fever.  
Immunosuppression - the disabling of the immune system - leaves the body vulnerable to 
even minor infections (Schoub 1999:24). In general, three kinds of infectious agents may 
attack the body:  
 
First, there are micro-organisms especially viruses which in HIV negative individuals 
cause acute but temporary illness. In immunosuppressed individuals these infections are 
more severe and prolonged.  
 
Second, there are organisms, particularly bacteria (causing tuberculosis, meningitis, 
salmonella, syphilis, gonorrhea, chlamydia and other sexually transmitted bacterial 
infections), fungi (causing, pneumocystis carinii pneumonia, candidiasis, cryptococcus 
and histoplasmosis) and parasitic organisms (causing pneumonia, toxoplasmosis, 
cryptosporidiosis, isosporiasis, scabies and malaria). In HIV negative individuals these 
infections cause disease, but are usually readily treated with drugs. In immunosuppressed 
individuals treatment of these infections are often difficult because there is no assistance 
from the T-lymphocytes. These infections persist for long periods and are often resistant 
to drugs.  
 
Third, there are infections with organisms of low virulence (cytomegalovirus, herpes 
zoster, herpes simplex, human papillomavirus and hepatitis B). Viruses, bacteria, fungi 
and parasites commonly cause opportunistic infections (Schoub 1999:24-31).   
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Infected individuals can live with the disease for years without knowing they are infected 
and during this period they can infect others. Therefore, it is important to diagnose 
infected individuals as early as possible to prevent them from infecting others.  
 
Figure 2.1: HIV subtypes and their geographical distributions  
 
 
After discovering HIV infection in Africa in 1983, it became evident that the 
characteristics of HIV in Africa, were different from those in Western Europe, North 
America, Australia and New Zealand. This latter pattern is known as HIV-11 subtype B. 
Sexual transmission of the HIV virus was concentrated in so-called high-risk groups, 
mainly homosexual and bisexual men and intravenous drug abusers, where prevalence in 
                                                  
1
 HIV is classified into two types, HIV-1 and HIV-2. Within HIV-1 are groups of similar 
viral strains. These are the major (M) subtype and non-M (new [N] and outlier [O]) 
subtypes. The majority of HIV-1 infections are by M-subtype viral strains. Subtype M 
HIV-1 is further broken down into nine genetically distinct strains known as clades. 
 
Clade: A group of organisms that are genetically similar and descended from a single 
parent organism. With HIV, the term "clade" refers to a group of specific HIV-1 strains 
within an HIV subtype. For example, HIV-1 subtype M contains clades A through H, J, 
and K. Clades B and C account for the majority of HIV infections around the world.  
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these groups may be up to 50%.  However, in the rest of the world’s population, HIV is 
uncommon and prevalence is usually less than 0.1% (Schoub 1999:24).  
 
Conversely, HIV-1 subtype C is mostly found in Sub-Saharan Africa, Central America 
and also inner city populations living in deprived socio-economic communities in the big 
cities of the U.S. It is also the most dominant form of infection in India and parts of 
China. These geographical regions have limited access to antiretroviral therapy, 
infectious diseases are more common and tuberculosis is the most common form of 
opportunistic infection (Morris et al. 2000:339). Infection is mainly transmitted by 
heterosexual intercourse, but with a predominance of female infection. There are several 
reasons for predominance of female infections in these areas. Females are biologically 
more susceptible to infections. Also, females in these regions have lower socio-economic 
status with lower employment levels.  As a result of their financial dependence on their 
partners they are unable to insist on safer sexual practices. Females are also vulnerable to 
sexual violence and sexual abuse (Budlender & Johnson 2002:9,26). Infection in these 
areas tends to be more common in urban than rural areas (Schoub 1999:24; Bartos & Piot 
2002:208; Budlender & Johnson 2002:34). Also, studies by Medley et al. (2004:4) 
showed that HIV positive females in developing countries who disclose their status, run 
the risks of being blamed, abandoned, lose economic support, physical and emotional 
abuse, discrimination and disruption of family and relationships.  
 
Lower infection rates in rural areas in many Sub-Saharan countries may be explained in 
terms of their immobility and geographic isolation. However rural communities in South 
Africa are not as static and geographically isolated as those in the rest of Africa 
(Budlender & Johnson 2002:34). The migrant labour system has caused a steady flow of 
HIV infected men through the rural communities to their families in rural communities, 
and the urban areas where they work (Whiteside & Sunter 2000:65; Budlender & Johnson 
2002:34).  
 
In South Africa the AIDS epidemic began with subtype B, predominantly in the higher 
socio-economic white population, affecting mainly homosexual men (Sher 1989:46; 
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1989:46; Williamson et. al. 1995:782; Schoub 1999:24; Budlender & Johnson 2002:38). 
In 1987 the first black person showed a subtype C infection. This is now the most 
dominant form of infection in this country (Sher 1989:46; Williamson et. al. 1995:782; 
Schoub 1999:24; Budlender & Johnson 2002:38).  
 
The progression from HIV to AIDS after initial infection varies from 2-20 years, with a 
median of nine years (Maartens 1999:1255). Research indicates that the median survival 
is shorter for individuals in Africa where subtype C dominates, than in industrialised 
countries (Morgan et al. 2002:597). The median survival of HIV infected individuals in 
developing countries is estimated at approximately 7 years (Boerma et al. 1998; 
Deschamps et al. 2000:2519; Merli & Palloni 2004:43; Costello et al. 2005:582). 
However, natural history studies of individuals with subtype C are limited (Morris et al. 
2000:339; Morgan & Whitworth 2001:143; Jaffer et al. 2004:462).   
 
The estimated survival time from seroconversion to AIDS in Africa is 4.4 years (Morgan 
& Whitworth 2001:143). Studies by Morgan and colleagues on HIV-1 patients in rural 
Uganda estimate the time from seroconversion to stage two of the WHO clinical case 
definition at 24.5 months. They also estimate the median time from seroconversion to 
stage three of the WHO definition at 45.5 months (Morgan et al. 2002:193). Only one 
study from Africa has reported the median time from seroconversion to death. The 
median survival was 9.8 years. However, patients in this study were using HAART 
(highly active antiretroviral therapy) which prolonged their life expectancy (Morgan et al. 
2002:601). 
 
Nevertheless, research indicates that viral subtype is not a major determinant of disease 
progression. Instead, host and environmental factors are major determinants of disease 
progression (Galai & Kalinkovich 1997:2; Adetunju 1998:17; Hogg et al. 1994:1120; 
Mugerwa & Ryder 1994:271; Mehendale et al. 2002:117). Host factors include age and 
ethnicity. Weiss (1993:1274) suggests that those infected in adolescence and early 
adulthood progress more slowly. For those infected from birth the progression from HIV 
to AIDS has a range of 1 to 6.3 years (Anderson 2003:39). Environmental factors, which 
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play an important role, are socio-economic status, access to health care facilities, and 
concurrent infection rates of sexually transmitted diseases (Alaeus 2000:32). Hogg and 
colleagues (1994:1120) suggest that there is a link between survival with HIV/AIDS and 
socio-economic status, the lower the socio-economic conditions, and the shorter the 
survival time. In Sub-Saharan Africa, one of the poorest regions in the world, the interval 
between diagnosis with AIDS and the time of death is very short (Adentuju 1998:17). A 
study in 1997 by Maartens (1999:1258) at the University of Cape Town showed that 
without antiretroviral therapy the median survival time of homosexual and heterosexual 
HIV infected persons after diagnosis of AIDS is eighteen months. 
 
 So, it is important that HIV positive individuals are diagnosed as early as possible to 
provide them with antiretroviral therapy. This will prolong their life expectancy and 
improve their quality of life. 
 
In addition the survival after development of AIDS is shorter in areas where resources are 
scarce and where only basic health care exists (Maartens 1999:1255; Mehendale et al. 
2002:117). This is because most patients in Africa cannot afford antiviral drugs used in 
the treatment of AIDS and HIV infection. In addition, most African health care facilities 
providing care for AIDS patients have limited capacity for diagnosing many AIDS-
defining opportunistic infections that occur in African patients. Therefore, many 
opportunistic infections occurring in African patients are left untreated or are improperly 
treated. Aggravating this situation is the fact that there are limited therapeutic options 
available in most African health care facilities for treating these opportunistic infections 
(Mugerwa & Ryder 1994:271). Another explanation is that nutritional deficiencies may 
contribute to increased immune suppression and lead to faster disease progression (Fawzi 
et al. 2002:422). 
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Moreover, diagnostic facilities for CD4 counting can be expensive and scarce in some 
areas in South Africa, especially in the rural areas of the Eastern Cape. Therefore, it is 
crucial to develop a clinical case definition that is cheap and easy to apply. Also, such a 
case definition must be able to recognize opportunistic infections clinically and as early 
as possible to be properly treated.  
 
2.3 HIV/AIDS diagnostic classification systems/case definitions 
Because HIV is relatively new to scientists, understandably different case definitions 
have arisen in various countries, depending on population factors (children, adults, 
relative occurrence of opportunistic infections) and on the laboratory infrastructure and 
training available (De Cock et al. 1991:1; Mugerwa & Ryder 1994:271; Schoub 
1999:37).  
 
Essentially the classification systems for AIDS consist of three major features: firstly, 
laboratory tests for HIV infection as well as for immuno-suppression; secondly, 
demonstration of what are called indicator diseases, that is the specific opportunistic 
infections or tumors which predict that the individual is at least significantly immuno-
suppressed; thirdly, cerebral manifestation of AIDS as well as other direct effects of the 
virus such as wasting (Whiteside & Sunter 2000:36). 
 
Given that HIV disease progression is so unpredictable there is a need for a 
comprehensive system to assist in prognosis, follow-up and timing for interventions 
(Maartens 1999:1255). Therefore, AIDS case definitions have changed to improve their 
specificity, i.e. the ability to avoid diagnosing people with clinically similar conditions to 
AIDS, but who do not have AIDS. Case definitions also improved their sensitivity, the 
ability to pick up as many AIDS cases as possible with the clinical criteria that comprise 
the definition (Schoub 1999:236).  
 
Thus, over the years HIV/AIDS case definitions have changed to distinguish between 
HIV positive and HIV negative individuals. In addition, case definitions were revised to 
diagnose as many as possible HIV/AIDS cases. These revisions are crucial for countries 
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in Sub-Saharan African, especially South Africa, with high HIV/AIDS prevalence rates. 
Also, case revisions are critical in areas where the majority of infected individuals are 
unaware of their HIV status and are infecting others. Consequently, they are spreading 
the disease.  
 
Two types of classification systems are used, namely, clinical staging systems that 
improve clinical care and management of patient care and case definitions that are used 
for surveillance purposes (Onin 2002:302). Clinical staging systems classify HIV/AIDS 
in a progressive sequence from least to most severe; each has a poorer prognosis or 
different medical management than the earlier stage (Osmond 1998:2). 
Several case definitions have been developed: 
The Centres for Disease Control Case Definitions: 1982, 1986, 1987, 1993; 
The World Health Organisation/Bangui Case Definition 1985; 
The Walter Reed Classification System (WRCS) 1986; 
The WHO Clinical Staging System 1989; 
Caracas case definition 1992. 
 
Additionally, African countries adapted AIDS case definitions, to suit local 
circumstances. The following case definitions were developed: 
Abidjan case definitions 1991; 
Symptomatic case definition, Uganda 1993; 
Gambian definition 1993; 
Zambian case definition 1993; 
Rwandan case definition 1995; 
Expanded WHO case definition 1994; 
Ugandan case definition 1999. 
 
The conditions and infections listed in the 1982 Center for Disease Control case 
definition of AIDS were developed primarily for epidemiologic surveillance. However, 
this case definition requires diagnostic and laboratory technologies that are not always 
available in developing countries.  Nevertheless, this CDC definition has been used as a 
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model in many countries (De Cock et al., 1993a:6). The 1982 CDC case definition was 
primarily designed to “enable field workers to carry out surveillance of the number of 
individuals affected and to monitor the progress of the disease” (Mugerwa & Ryder 
1994:276). 
 
The WHO-Bangui classification system was developed in Bangui, in The Central African 
Republic, in 1985 (see Appendix A) in response to the need for a surveillance definition 
that did not require special laboratory or diagnostic equipment as required by the 1982 
CDC case definition (Weniger et al. 1992:1213; Durovni  et al. 1993:1054). The new 
case definition relied on clinical criteria alone without the need for serologic verification. 
It is with this parallel system in mind that many developing countries have adapted this 
classification system to suit local circumstances since illnesses associated with immune 
deficiency may vary according to the disease-causing organisms in different regions. In 
the absence of known causes of immuno-suppression, e.g. cancer, severe malnutrition or 
other recognized etiologies this classification system requires low major signs (De Cock 
et al. 1993a:6; Onin 2002:300; Weniger et al. 1992:1213).  It has served a useful purpose 
in surveillance activities in Africa. The fact that no serologic HIV testing is required to 
define a case of AIDS has greatly facilitated its use in areas where HIV serology testing 
is not available (Mugerwa & Ryder 1994:274). 
 
In 1986, the CDC developed the first surveillance case definition (see Appendix B). 
However, this definition is complex, although comprehensive and universally 
standardized. Its primary purpose is surveillance and not the practical care of patients 
(Onin 2002:300). The 1986 CDC surveillance definition is generally inappropriate for 
Africa because of limited diagnostic facilities (Mugerwa & Ryder 1994:276).  
 
Also in 1986, Redfield and colleagues (Mugerwa & Ryder 1994:278; Onin 2002:301) 
designed the Walter Reed Staging Classification (WRSC). Like the CDC case definition, 
the WRSC is better suited for the needs of developed countries since it requires expensive 
serological testing not easily available in the developing world. This definition relies on a 
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combination of four clinical and laboratory components: lymphadenopathy; CD4 counts; 
thrush; and delayed hypersensitivity reaction.  
 
The dependence of the WRSC on CD4 counts, as well as cutaneous response to four 
tests’ antigens, limits its usefulness in most surveillance activities and studies of the 
natural history of HIV infection in Africa (Mugerwa & Ryder 1994:278; Onin 2002:301).  
The CDC case definition for AIDS was first revised in 1987 (Osmond 1998:6-7). The 
adult case definition was broadened to include: 
HIV encephalopathy and HIV wasting syndrome; 
Diagnoses made presumptively in cases with laboratory evidence of HIV 
infection; 
The elimination of exclusions due to other causes of immunodeficiency in 
cases where laboratory evidence of HIV infection (Osmond 1998: 6); 
The paediatric case definition for surveillance was broadened to include 
multiple or recurrent serious bacterial infections, lymphoid interstitial 
pneumonia or pulmonary lymphoid hyperplasia in children under 13 years old. 
 
Still, this case definition was not adequate to capture all cases of severe HIV-related 
immunodeficiency. Further expansion of this definition was suggested to include other 
clinical conditions (Osmond 1998:7). Consequently, this revision of the 1987 CDC case 
definition indicates that case definitions are not universally applicable. In addition, new 
knowledge about the disease is responsible for the improvement of HIV/AIDS case 
definitions.  
 
In 1989 the World Health Organization proposed a Clinical Staging System (see 
Appendix C) that was developed in response to the limitations of the WHO Bangui 
definition. The WHO Bangui classification system was developed to enable reporting of 
the numbers of people with AIDS for the purposes of public health surveillance, rather 
than patient care. It does not include everyone with symptomatic infection, but only those 
with severe AIDS diseases (Mugerwa & Ryder 1994:274). Furthermore, not all HIV 
positive patients have AIDS. Some are dying of HIV-related illnesses not recognized as 
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AIDS (De Cock et al. 1993a:6; Mugerwa & Ryder 1994:274). This is especially the case 
with tuberculosis (TB) patients. The AIDS pandemic has the most profound effect on TB 
prevalence in Africa and is responsible for the dramatic increase in the prevalence there. 
Furthermore, TB is also the leading cause of death in persons infected with HIV (Ridzon 
& Mayanja-Kizza 2001:374). There has been widespread concern that many HIV-
seronegative patients with TB would be counted incorrectly as AIDS cases in any clinical 
case definition used in Africa.  
 
Moreover, findings by Colebunders (1989:902) highlight the difficulty of clinically 
distinguishing an HIV-infected person from a HIV-seronegative person with TB. Many 
patients with tuberculosis, regardless of their HIV status, experience weight loss, fever, 
and cough, decreasing the specificity of the WHO case definition in this sub-population. 
Thus, without HIV testing, many HIV-seronegative tuberculosis patients will be 
classified incorrectly as having AIDS. However, if tuberculosis is excluded from the case 
definition, one of the most frequently HIV associated diseases will go unreported. This 
definition also fails to include neurological manifestations of AIDS in the definition 
(Mugerwa & Ryder 1994:274). Colebunders, therefore, suggests that all TB patients in 
Africa be screened for HIV (Mugerwa & Ryder 1994:274).  
 
Again, this revision highlights the significance of a classification system that recognizes 
local opportunistic infections. This would enable health facilities to pick up HIV positive 
individuals as early as possible. Subsequently, providing them with antiretroviral therapy 
and counselling, to prevent the spread of the disease. 
 
In 1989 WHO Clinical Staging System was aimed at improving clinical management of 
patients and to assist clinicians to make a more reliable prognosis. It would also enable a 
better definition of the natural history of HIV infection (Mugerwa & Ryder 1994:274). 
The system is based on four groups of clinical conditions that are considered to have 
prognostic value and therefore constitute four stages, plus an assessment of physical 
activity performance expressed as a four-point score. Patients are classified according to 
the highest stage recorded for either clinical conditions or physical activity (Osmond 
 
 
 
 
 19
1998:5). Patients may move to a more advanced stage, but cannot then return to an earlier 
stage. This system is easy to apply and allows for separation of clinical and laboratory 
staging (Maartens 1999:1255). 
 
The 1989 WHO definition was supposed to be universally applicable (Mugerwa & Ryder 
1994:274). The development of this clinical staging system illustrates the importance of 
recognizing HIV clinically without expensive diagnostic laboratory testing as facilities 
could be scarce.  
 
Further, the WHO/Bangui clinical case definition was also inapplicable in South America 
because it did not take account of available serology and other diagnostic resources of 
this region. It included presumptive criteria for diagnosing AIDS in patients with TB, 
pneumocytis carinii pneumonia and other terminal cases. This definition based on the 
CDC definition, required a positive serologic test (Weniger et al. 1992:1214).  
 
In addition, none of the other case definitions mentioned above was applicable for 
countries in South America. Consequently, the Caracas case definition was developed in 
1989 to simplify and standardize AIDS surveillance in Brazil, Honduras and Suriname. 
These countries had diagnostic resources that were intermediate between the developed 
and the developing world. However, unlike the WHO/Bangui definition, the Caracas 
definition still required a positive serologic test (Gallant et al. 1992:295-296).   
 
In 1991, the Pan-American Health Organization used data from the Brazilian study to 
develop a simplified clinical case definition of AIDS for adults for potential use of 
epidemiological surveillance in this region. This revised Caracas definition (Appendix D) 
was developed because of a need for a clinical AIDS definition in countries where the 
CDC case definition is not practical. This case definition defines a person as having 
AIDS when cumulative points assigned for conditions, equal or exceed 10, and show 
antibodies for HIV in serum. Furthermore, cases in which the total point score equals or 
exceeds the required score of 10, but HIV serology is pending are considered 
“provisional cases”. This case definition excludes persons with cancer, or 
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immunosuppressive therapies, or where the signs/symptoms are attributed to conditions 
other than HIV infection (Weniger et al.1992:1213).  This revision illustrates the 
significance of using medical data to revise and improve current case definitions to 
include prevalent opportunistic infections.  
  
The 1993 CDC revision (see Appendix E), categorizes persons on the basis of clinical 
conditions associated with HIV infection and CD4 T-lymphocyte counts. The system is 
based on three ranges of CD4 T-lymphocyte counts and three clinical categories and is 
presented by a matrix of nine mutually inclusive categories. The CD4 lymphocyte 
categories correspond with CD4 –lymphocyte counts per micro litre of blood (Mugerwa 
& Ryder 1994:276; Onin 2002:299).  
 
According to this classification system any HIV-infected individual with a CD4 T-
lymphocyte cell count <200/mm3 has AIDS by definition, regardless of the presence of 
symptoms or opportunistic infections (Onin 2002:299-300). This revision of the CDC 
case definition again shows the importance of a clinical staging in areas where diagnostic 
resources are scarce.  
 
2.4 Application of the World Health Organisation/Bangui Definition in Africa   
A study by De Cock and colleagues (1991:1185) in Abidjan found that not all people who 
tested positive for fully-blown AIDS have early HIV-infection. Some may have advanced 
disease associated with HIV infection, but do not meet the AIDS case definition. This is 
because it is difficult to make a distinction between an HIV-positive TB patient and an 
HIV-negative patient. The WHO/Bangui clinical case definition is thus unsatisfactory 
because this definition does not require a positive serologic test. Therefore, a 
modification of the WHO clinical case definition of AIDS in Africa was proposed. This 
was called the Abidjan or “AIDS Wasting” definition (see Appendix F). In this 
classification scheme an adult would be classified as having AIDS if the CDC 
surveillance case definition for AIDS was fulfilled or patients had a positive test for HIV 
infection plus one or more of the following symptoms: weight loss with diarrhoea or 
fever, TB, Kaposi’s sarcoma or nerve disorders. This proposed scheme provides the 
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simplicity required in any case definition in Africa, but also requires a positive HIV 
serologic result (De Cock et al, 1991:1185; Mugerwa & Ryder 1994:279). The use of the 
HIV Wasting Syndrome as indicative of AIDS not only excluded all HIV-seronegative 
patients (by definition), but also increased the sensitivity of the case definition (Mugerwa 
& Ryder 1994:273). It is a simple staging system of HIV-infection and disease and will 
be more useful and effective than a surveillance case definition. It was primarily 
developed for epidemiological surveillance and may not be adequate for clinical work 
(De Cock et al. 1991:1185).  
 
Furthermore, studies by De Cock and colleagues (1993a:6) in Uganda and Côte d’Ivoire 
found the WHO/Bangui clinical condition “relatively specific” meaning that the vast 
majority of people diagnosed as having AIDS will have been correctly assessed.  
However, studies show that the definition is relatively insensitive, meaning that only 
patients who have severe illness related to HIV will be included in the definition. TB is 
widely recognized as the most common opportunistic disease associated with AIDS in 
Africa. However, because TB causes wasting, cough and fever in most patients, the AIDS 
definition cannot reliably distinguish between HIV-positive and HIV-negative patients. It 
does not include everybody with symptomatic HIV infection, but only people with severe 
HIV disease.  
 
Therefore, in South Africa where TB is prevalent, HIV/AIDS case definitions should 
reliably distinguish between HIV-positive and HIV-negative TB patients.  
 
In response to this research the Symptomatic HIV case definition was developed for  
Uganda and Côte d’ Iviore in 1993 for the purpose of individual case management. It is 
useful for diagnosis, if illnesses are related to HIV infection (symptomatic HIV 
infection). In the Symptomatic definition, a person is asymptomatic when he/she has 
Herpes Simplex Virus infection and is healthy, although there may be signs of persistent, 
generalized lymphadenopathy. Symptomatic infection or HIV disease is diagnosed when 
a person has HIV infection together with illnesses related to immune deficiency. These 
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illnesses may be mild, moderate or severe. They are characterized, by episodes of illness, 
followed by recovery and periods of health (De Cock et al. 1993a:6).  
 
Furthermore, De Cock and colleagues associate the following conditions, which are not 
included in the CDC definition, with HIV in women: amenorrhea; recurrent or persistent 
vaginal candidiasis; severe pelvic infections with abscess formation and cervical cancer. 
Although the Symptomatic definition does not intend to replace the WHO/Bangui clinical 
case definition developed for epidemiological purposes which avoids the over-use of HIV 
testing. HIV testing in this case is used to confirm suspected HIV infection rather than as 
a diagnostic tool. In addition, a patient with suspected HIV infection can be counselled. 
Also, many HIV related illnesses can be treated, improving the patient’s quality of life. 
Furthermore, certain drugs cause severe side effects in people with HIV infection, and 
should not be prescribed incorrectly (De Cock et al. 1993a:6) or without proper 
infrastructure. 
 
Although more exact than the WHO/Bangui clinical definition, the Symptomatic case 
definition requires more invasive diagnostic tests and is more complicated for health 
workers to use. Symptomatic HIV infection can be recognized clinically without testing 
for HIV antibodies. However, confidential HIV testing can be used to confirm a clinical 
diagnosis provided that patients give their consent and are counselled before such a test 
(De Cock et al. 1993a:6). 
 
Thus, it is critical to select a clinical staging system, especially in the Eastern Cape, 
where diagnostic facilities are scarce in rural areas. By doing this, HIV positive 
individuals can be clinically recognized and provided with antiretroviral therapy and 
counselling, which will prevent them from spreading the disease. 
 
In 1993, the WHO/Bangui clinical case definition was also adapted for surveillance of 
Gambian patients. The Gambian system also required that patients should be seropositive 
(antibodies in serum) for HIV. The Gambian system shows that immune damage is 
closely correlated with the stage of disease based on WHO/Bangui definition of AIDS, 
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the WHO Clinical Staging System, or that developed by the CDC. It substantiates that 
CD4 counts are a powerful predictor of survival in symptomatic Gambian patients. The 
Gambian or WHO clinical staging system is easy and cheap to apply and may serve as an 
alternative to sophisticated and expensive immunological measurements when trying to 
stage or predict prognosis (Whittle et al.1993:45-49). 
 
In 1993 Zambia also adapted the WHO/Bangui clinical case definition to suit local 
circumstances and designed local major and minor criteria for the clinical case definition 
of AIDS. The Zambian National AIDS Surveillance Committee evaluated the WHO case 
definitions and found in a preliminary study of children in Zambia that a number of 
patients with obvious AIDS did not fit the WHO case definition for paediatric AIDS.  On 
the basis of these findings they suggested that children with HIV infection who would 
need special care should be identified at a primary health level. They also recommend 
that AIDS researchers in Africa work out their own criteria and case definitions of 
paediatric and adult AIDS for use at national level. When fully evaluated locally, these 
criteria could be analyzed between regions to seek a unified case definition if possible 
(Chintu & Zumia 1993:1054).  
 
Further studies (Lifson et al. 1995:262) in Rwanda in 1995 suggested the following major 
modifications to the WHO clinical staging system for use in Sub-Saharan Africa: 
defining oral candidiasis, pulmonary tuberculosis (PTB) and chronic oral and genital 
ulcers as stage 4 conditions and replacing weight loss with body mass index.  
 
In 1997, Greenberg and colleagues compared the 1985 WHO/Bangui clinical case 
definition with the 1994 Expanded WHO case definition. This research involved patients 
from three university hospitals in Abidjan and TB patients from eight TB centres in Côte 
d’Ivoire. The following proposals were made: the inclusion of multiple severe HIV-
related illnesses in the expanded definition increased the number of reportable AIDS 
cases in HIV-seropositive patients and the inclusion of HIV seropositivity as a criterion 
for the expanded definition. Thus, it includes seropositivity as a criterion for the 
expanded definition to increase its specificity. Based on these findings, researchers 
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recommended the use of the 1994 expanded definition for surveillance purposes in areas 
of the developing world where HIV serologic testing is available (Onin 2002:301).  
Another African country that adapted the WHO/Bangui clinical case definition was 
Uganda. In 1999 the Ugandan Medical Research Council conducted research in rural 
Uganda. Its objective was to assess whether the WHO staging classification for HIV 
provided prognostically valuable and applicable information in rural Uganda. Their 
findings prompted a revised clinical staging system. Bacterial infection and unexplained 
prolonged fever for more than one month should be considered as an asymptomatic 
condition. Cryptosporidiosis or HSV infection for more than one month should be 
considered as persistent generalized lymphadenopathy (PGL) condition and oral 
candidiasis should be considered as a symptomatic condition. Furthermore, the study 
suggests that: PTB and Extra pulmonary tuberculosis (ETB) are associated with a better 
prognosis than other stage 3 and 4 conditions. Body mass index is a better prognosis 
marker than weight loss.  When total CD4 counts were used combined with clinical 
conditions, there was evidence to suggest that the combination provided prognostically 
better staging when only clinical conditions or total lymphocyte counts (TCL) were used 
independently. This work has shown that WHO clinical condition categories are good 
indicators of disease progression even without being revised to incorporated laboratory 
categories. This is important for areas with limited access to laboratory markers 
(Malamba et al. 1999:2555-2561).  
 
Research by Maartens in 2000 in Cape Town suggests that AIDS Defining Illness (ADI) 
is an important determinant of survival, particularly in patients with preserved CD4 
counts. Therefore, opportunistic disease could be used as a prognostic adjunct to CD4 
counts. This means that stratification of patients can easily be performed in poor resource 
areas. Expensive therapy can then be limited to patients with favourable prognostic 
criteria, while survival figures of people in stage four, suffering from diseases such as 
Wasting Syndrome or encephalopathy, support the institution of home-based terminal 
care (Post et al. 2001:585-586).  
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The prognostic management provided by opportunistic disease can be used for 
counselling and management of HIV infected patients. Moreover, prognostic 
stratification can also be used to avoid irrational spending of scarce health resources (Post 
et al. 2001:585-586).  
 
Thus, based on medical data, HIV/AIDS case definitions in Africa are continuously 
revised, to include regional opportunistic infections. In addition, changes in case 
definitions are determined by available diagnostic facilities.  
  
2.5 Conclusion 
Regional differences of opportunistic infections and different diagnostic facilities 
available in countries have determined dynamic changes in classification systems. The 
Centres for Disease Control and Walter Reed Classification System, which require more 
advanced diagnostic facilities and are therefore more suitable for the developed world. 
The WHO/ Bangui case definition or a refinement, requires no serologic testing, is better 
suited for the developing countries especially in Africa. Some African countries (Côte 
d’Ivoire, Gambia, Zambia, Rwanda and Uganda) have adapted this WHO/ Bangui case 
definition to suit local circumstances. Meanwhile, South American countries that have 
intermediate diagnostic facilities use the Caracas and Revised Caracas case definition that 
require some serologic testing. Finally, studies of the WHO Clinical Staging System in 
South Africa, suggest that AIDS defining illness is a useful predictor of survival and 
stratification of AIDS and should be applied in the management of the disease. To this 
end the various clinical signs and symptoms have been developed into a table (see 
Appendix H), which can then be applied to the case level data already collected in Region 
A, health district of the Nelson Mandela Metropole. 
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Chapter 3 
Research design and methodology 
 
3.1 Introduction  
This chapter delimits the study area and explains the rationale behind the data analysis. 
What follows is a description of the research design and methodology applied to staging 
the disease based on the WHO Clinical Staging System (WHO CSS).  
 
3.2 Study Area  
Figure 3.1 Eastern Cape  
 
Source: Statistics South Africa  
 
The Eastern Cape is South Africa’s second largest province encompassing 15% of the 
country’s land mass. The province is considered to be the poorest in the country and the 
most vulnerable to HIV/AIDS (Shell 2000:2).  
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Moreover, Census 2001 revealed that the province is home to 15.5% of the total 
population of South Africa (StatsSA 2004:4). Also, over one third of the population, 
36.8% in the area are under 15 years. A further 6.2 % were 65 years and older and 64.4% 
were aged 29 years or younger (StatsSA 2004:19).  
 
In addition, a report by the Department of Health (DOH) in 2005, estimates HIV 
prevalence among HIV antenatal attendees in the Eastern Cape at 29.5% (DOH 2006:11). 
Further, research at the Human Science Research Council in 2005, estimates that HIV 
prevalence in the age group two years and older in the Eastern Cape is 8.9%. Among 
people in their reproductive years HIV prevalence was 15.5 % (Shisana et al. 2005:35).  
 
However, the highest infections are not in poor rural areas, but in urban areas of the 
Nelson Mandela Metropole (NMM). HIV prevalence is highest amongst Blacks, growing 
amongst people of mixed descent and lowest and declining amongst Asians and Whites in 
the city. The disease has spread rapidly amongst the black population in the city (Shell 
2000:2-3). 
 
To explain the severity of the epidemic in South Africa, Whiteside & Barnett (1999) 
developed the Jaipur Paradigm, to explain this phenomenon. How many people are 
infected, the rapid the spread among the black population, will be determined by two key 
variables: (i) the degree of social cohesion in society, and (ii) the overall level of wealth. 
 
Social cohesion needs further explanation. It may derive from civil society, that part of 
society which occupies the space between the individual and the state, and the degree 
to which there is a perceived and acted-upon community of interest in a group or 
nation. It includes voluntary organisations, NGOs, churches, parent-teacher 
associations, indeed any grouping of people outside the household and workplace. 
Social cohesion may also stem from control through an authoritarian political or 
cultural system or from national beliefs and ideologies, especially organized religion. 
The unit of analysis may be a whole society but also may be a household or sub-
community (Whiteside & Barnett 1999:17). 
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Wealth is simply the level of income per head. When combined, four types of societies 
emerged.  
Type 1, high social cohesion and high wealth - many societies of the rich world;  
Type 2, high social cohesion and low wealth - those societies with strong religious 
cultures or good governance;  
Type 3, low social cohesion and low wealth - countries experiencing civil war or 
economic collapse, such as Uganda in the early 1980s;  
Type 4, low social cohesion and high wealth - societies in transition, such as South 
Africa, where wealth is very unequally distributed (Whiteside & Barnett 1999:17).  
 
In societies with high income and low social cohesion, truck drivers may earn a relatively 
high income. However, by the nature of their work, it is also difficult to bring them into 
contact with Information Education Communication programmes (Whiteside & Barnett, 
1999:17; Whiteside & Sunter 2000:65). Whiteside & Sunter (2000:65) explained this 
theory in the South African context: by applying this conceptual framework to South 
Africa, one can explain why the epidemic is so severe to date; why it is located where it 
is; and what may happen.   
 
Under apartheid, the country was subject to extreme social engineering, designed to 
benefit the minority white population. South Africa’s black population was forced into 
crowded, impoverished homelands, which led to the breakdown of traditional cultural 
structures. Adult men migrated to urban areas to work in white-owned factories and 
mines and to live in single-sex hostels. The laws of the regime prohibited them from 
bringing their families into the cities (Whiteside & Sunter 2000:65; Marks 2002:18). This 
created a culture of urban and rural wives and prostitution, not necessarily for cash but as 
part of a survival strategy. Adults, other than their parents, cared for many children. As 
result of these family break-ups, child abuse and child prostitution became a new 
phenomenon. Health services were limited, which meant many sexually transmitted 
infections (STIs) went untreated. The pattern of men moving away from their families for 
long periods, living in crowded and alien conditions with little power over their lives, 
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created the ideal situation for the spread of all STIs (Whiteside & Sunter 2000:65).  
Additionally, the migrant labour system has caused a steady flow of HIV infected men 
through rural communities (Whiteside & Sunter 2000:65; Budlender & Johnson 
2002:34).  
 
Further, the demise of apartheid did end ‘temporary’ migration. Posel (2003:16;17) 
provided evidence that the migrant labour system continued until 1999. This research 
also suggests, that people still migrate ‘temporarily’, retaining membership in, and ties 
with, their households of origin. Moreover, research by the Southern African Migration 
Project in 2004, provided evidence that migration is a important factor in the spread of 
HIV in Southern Africa (Lurie 2004:23).  
 
Contributing to the spread of HIV, the apartheid system through legislation and 
formalization of discrimination through education, jobs, and even the regulation of sexual 
behaviour between race groups was responsible for the creation of the “widespread 
philosophy of fatalism. A perception of  ‘what will be, will be’ arose which in turn 
diminished individual worth, responsibility, and accountability. This feeling is still 
prevalent and makes people live for today without valuing tomorrow” (Whiteside & 
Sunter 2000:65). 
 
Further, conflict during the final years of apartheid, the cycle of oppression and resistance 
led to the almost total disruption of civil society (Whiteside & Sunter 2000:65). There 
was a militarization of society. Armed forces included the defence force, homeland 
armies, liberation movements, self-defence units and political militias. Military forces 
have higher levels of infection than the general population (Whiteside & Sunter 2000:65). 
The violence that categorized the end of apartheid has not disappeared, except in its 
political form (Marks 2002:20). 
 
Moreover, the steady migration of large numbers of sexually active males bringing their 
diseases with them resulted in the marginalisation of women and children (Marks 
2002:18). Therefore, inequality within society assisted (and continues to assist) the 
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spread of HIV. Poor women have fewer financial resources and are forced into sexual 
relationships to ensure the survival of themselves and their children (Whiteside & Sunter 
2000:65). In single-sex hostels black men were able to exert power over women who 
were in town illegally and were dependent on men for a bed (Ramphele 2000:114; Marks 
2002:21). These women became vulnerable to sexual exploitation which contributed to 
the spread of HIV.  
 
Additionally, in the Eastern Cape sexual violence was increasing, soon becoming like a 
“war on women”. This war on women was the outcome of a complex interaction between 
broader social processes and those of gender power relations, themselves mediated by 
economic and political factors (Mager 1998:16; Marks 2002:20). Murder, rape and 
assault are now both cultural and statistical norms and seem to have escalated since 1994 
(Turshen 1998:9; Marks 2002:21). Crime and gang violence are the main sources of 
conflict in South Africa. As a result, rape and gang rape have become  extremely 
effective methods of spreading HIV (Whiteside & Sunter 2000:65).  
 
Aggravating the situation, are cultural factors such as the belief that sleeping with a virgin 
can cure the disease (Shell 2000:2; Marks 2002:21).These beliefs are setting off higher 
infection rates amongst young females and children.  Furthermore, the taxi industry and 
migration contribute to high infection levels (Shell 2000:2-3). This sets a grim 
demographic future for the province. Therefore, information on the life expectancy of 
AIDS patients in the region is vital for government to develop health and welfare policies 
to increase the life expectancy of HIV positive individuals.  
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So, the Actuary Society of South Africa used the four stages of the WHO CSS (see 
Appendix C) to estimate the proportion of HIV positive people in the Eastern Cape. 
Findings of Dorrington and colleagues suggest that, in the year 2000, 62% of people 
living with HIV/AIDS were in stage 1. A further 18% were in stage 2 and 15% were in 
stage 3. The remaining 5% were in stage 4 (Dorrington et al. 6: 2002). 
 
Table 3.1: Stage of HIV infection in the Eastern Cape  
WHO Stage 1: Acute HIV Infection 62% 
WHO Stage 2: Early Disease  18% 
WHO Stage 3: Late Disease 15 % 
WHO Stage 4: AIDS 5 % 
Total 100% 
Source: Dorrington et al. 6:2002 
 
Thus in the year 2000, 62% of HIV positive people in the Eastern Cape were 
asymptomatic. Without voluntary HIV testing these individuals will only seek testing 
when they are symptomatic (show symptoms of HIV). Therefore, it is important that a 
concerted effort is made to diagnose these individuals before they become symptomatic.  
 
3.3 Hypotheses 
Patients in the NMM seek HIV testing when they are in the advanced stages three (late 
disease) and four (AIDS) of the World Health Clinical Staging System of HIV/AIDS (see 
Appendix C). The following null hypotheses relating to the diagnostic stage at the time of 
the HIV test will be tested, using the Chi-square test:  
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H01: There is no significant difference between males and females with regard to 
diagnostic stage. 
H02: There is no significant difference between population groups in relation to 
diagnostic stage. 
H03: No significant difference exists between age groups with regard to diagnostic 
stage. 
 H04: There is no significant difference regarding the type of dwelling relating to 
the stage at the time of HIV testing. 
H05: No significant difference exists between urban/ rural areas and diagnostic 
stage. 
H06: The diagnostic institute is not play a significant role in relation to the stage at 
the time of HIV testing.  
 
3.4 Methodology  
3.4.1 Data collection and sampling  
Anonymous case level data from January 1991 to April 2000, were collected from the 
Region A health district in the Eastern Cape. These records comprise 27 505 cases from 
the AIDS Training Information and Counselling Center (ATICC) in the Nelson Mandela 
Metropole. HIV testing was voluntary and blood samples were diagnosed at the South 
African Institute for Medical Research, using the ELISA /Western Blot test.2 
 
The data consist of 44 variables, of which the following were analyzed: population group; 
gender; age; diagnostic date; death date; diagnostic institution; mode of HIV 
                                                  
2
 HIV ELISA/Western Blot is a set of blood tests used in the diagnosis of chronic 
infection with human immunodeficiency virus (HIV). The HIV ELISA is a screening 
test for the diagnosis of HIV infection. If this test is positive, it must be confirmed with a 
second test called the Western Blot, which is more specific and will confirm if someone 
is truly HIV positive (there are other conditions that may inaccurately produce a positive 
ELISA test result, including lupus, Lyme disease, and syphilis). 
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transmission; type of dwelling; urban/rural residence and medical reasons for HIV 
testing.  
 
3.4.2 Research design /data analysis 
The why-variable (why did the patient go for an HIV test) was sorted into medical 
symptoms and non-medical conditions.  
Then, medical symptoms were classified using the WHO International Classification for 
Diseases 10 for HIV disease (see Appendix G). 
Subsequently, medical symptoms were stratified consistently with the four stages of the 
WHO CSS (see Appendix H).  
 
3.5 Rationale behind data analysis  
To estimate the asymptomatic phase we need to know the exact date the individual was 
infected. This data can be obtained through epidemiologic surveillance using case 
definitions of AIDS.  Since, the infection date was unavailable for all cases the researcher 
used a surrogate, disease progression staging system, which can be established using the 
medical symptom of patients during the HIV test. To stage the disease a diagnostic 
classification system is required. For this purpose the WHO CSS was found to be the 
most applicable for South Africa because it does not require expensive diagnostic 
facilities that are not accessible to everybody. This is tabulated carefully in Appendix C. 
The WHO CSS is cheap and easy to apply in areas with poor diagnostic facilities, such as 
the Eastern Cape. However, we need to review this definition to suit South African 
circumstances. Furthermore, research in Uganda in 1999 found the WHO CSS categories 
to be good indicators of disease progression even without being revised into laboratory 
categories (Malamba et al. 1999: 2555-2561). Further research by Maartens (1999: 1255) 
on the WHO CSS in 2000 in Cape Town suggests the use of opportunistic illness as 
prognostic adjunct to CD4 counts.  
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3.6 Minimizing errors 
The sort and frequency procedure was used to find and define missing data. Also, 
medical symptoms were cleaned and stratified. To minimize errors, the stratified medical 
symptoms were then checked by a clinical nurse with experience in HIV CD4 counting. 
She is experienced in this field as she assists with CD4 counting at a Medical Aid 
company, where CD4 counting is used to determine the stage of an HIV positive 
individual. Antiretroviral therapy is provided if the individual’s CD4 count is below 200 
cells/mm3 or if they have opportunistic infections associated with stages three or four of 
HIV that may be life threatening.  
 
3.7 Conclusion  
Case level data of HIV positive patients were collected from Region A, health district in 
the Nelson Mandela Metropole. Medical symptoms of these patients were first classified 
consistent with WHO International Classification for Diseases 10 for HIV. Afterwards 
medical symptoms were staged consistent with the categories of WHO Clinical Staging 
System. Subsequently, several null hypotheses relating to diagnostic stage of HIV 
positive people will be investigated. These results will be discussed in Chapter 4. 
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Chapter 4 
Results 
 
4.1 Introduction  
In this chapter, the results obtained from the AIDS Training Information and Counselling 
Centre (ATICC) will be presented and described. Moreover, the diagnostic stage at the 
time of the HIV test will be determined, using the World Health Clinical Staging System 
and the International Classification for Diseases (ICD 10). This chapter also probes 
whether there is dependence between the diagnostic stage and critical variables such as; 
gender, population group, diagnostic age, area type, diagnostic institution, dwelling type 
and year of diagnosis respectively.  
 
4.2 Demographic profile of HIV positive people  
Overall 27 505 HIV positive cases were recorded at the ATICC, from January1991 to 
April 2000. 
 
4.2.1 Gender and age composition 
 
Figure 4.1: Age and gender composition of HIV positive people, NMM 
 
Source: NMM ATICC, 2000 (N=27505)
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Figure 4.2: Gender of HIV positive people, NMM 
 
 
 
Source: NMM ATICC, 2000 (N= 27 505)
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Females accounted for almost two-thirds, 63.6% of recorded HIV positive infections in 
the Nelson Mandela Metropole (NMM), while males accounted for more than a third, 
35.8%. In 0.6% of all cases the gender of individuals was not recorded (see Figure 4.1; 
Figure 4.2 & Table 4.2). 
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In this study, the majority of HIV positive people were in their reproductive years (15 to 
49 years old), which also include part of the labour force. For people over 65 years old, a 
higher proportion of males than females were diagnosed with HIV (see Figure 4.1 & 
Table 4.1). 
 
To see the impact of HIV on infants less than 1 year old, a special category for this 
particular age group was created. The results suggest that 7% of the total group studied 
were infants under one year old (Table 4.1b).  
 
Moreover, the mean age of HIV positive people in this study was 27.23 years the median 
age was 28 years and the mode, 29 years. The standard deviation = 11.9 and the 
interquartile range = 12 (see Table 4.3b).  
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4.2.2 Population group 
 
Figure 4.3a: Population group census 1996, NMM 
 
Source: Census 1996, SSA (N=10 6062)
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During the 1996 census, over half, 52.1%, of people in the Nelson Mandela Metropole 
identified themselves as being Black. Whilst 28.6% identified themselves as being from 
mixed descent, 17.3% identified themselves as Whites and 0.9% identified themselves as 
Indians. For 1.1%, the population group was not recorded (see Figure 4.3a & Table 4.4a).  
 
Figure 4.3b: Population group of HIV positive people, NMM 
 
Source: NMM ATICC, 2000 (N= 27 505)  
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In this study, 92, 6% of people who seek HIV testing were Black, compared to 6.5% 
people of mixed descent and 6.5% and 0.7%  Whites. No Indian/Asians were tested HIV 
positive.  For 0.1% of individuals, population group was unknown (see Figure 4.3b & 
Table 4.4.b) 
 
4.2.3 Mode of HIV transmission  
 
Figure 4.4: Mode of HIV transmission, NMM 
 
 
Source: NMM ATICC, 2000 (N= 27 505)
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The mode of transmission was already recorded on the database. In this study 
heterosexual infections accounted for more than two thirds, 66.7%, of HIV infections in 
the area, while mother to child transmission accounted for 5.9%. The rest (rape, bisexual, 
homosexual, haemophiliac and other modes of infections) accounted for 0.3%. For the 
remaining 27.1% the mode of transmission was not recorded (see Figure 4.4 & Table 
4.5).  
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4.2.4 Diagnostic institution  
The majority, 56.7%, of HIV positive individuals were diagnosed at hospitals, followed 
by clinics, 25.9%, at private doctors, 8.5%, at TB hospitals 0.8%, at the Eastern Cape 
Blood Transfusion services, 1.3% and at prisons 1.2%. Diagnosis for insurance purposes, 
military hospitals, district surgeon and industry accounted for 5.3% of cases. In 0.2% of 
cases the diagnostic institutions were not recorded (see Table 4.6). 
 
4.2.5 Place of residence 
 
Figure 4.5: Place of residence of HIV positive people, NMM 
 
Source: NMM ATICC, 2000 (N= 27 505)
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Regional origins of HIV positive people in this study indicate that, 46.2% were from 
urban areas, while 6.3% were from rural areas and 1.4% were from other areas. In a 
further 46.0% of cases, the area type was not recorded (see Figure 4.5 & Table 4.7). 
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4.2.6 Dwelling type 
People with street addresses accounted for the majority, 66.4%, of recorded cases, 
whereas, 22.2% of HIV positive people lived in sites with services (informal settlements 
provided with water and toilet facilities). The rest (prisons, flats, hostels, farms, business 
etc.) each accounted for 3% or less. In 57.7% of cases the dwelling type was not recorded 
(see Table 4.8) 
 
4.2.7 Diagnostic year  
 
Figure 4.6: Year in which HIV positive people were diagnosed, NMM 
 
 
Source: NMM ATICC, 2000 (N= 26 303)
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The researcher has excluded the year 2000 because the data was collected only up to 
April 2000. Of the 26 303 cases, 0.7% were diagnosed HIV positive in 1991, compared to 
24.5% in 1999 (see Figure 4.6 & Table 4.9).  
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4.2.8 Diagnostic stage  
 
Figure 4.7: Diagnostic stage (1989 WHO Clinical Staging System), NMM 
 
 
 
Source: NMM ATICC, 2000 (N= 4772)
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Staging was done according to the 1989 World Health Clinical Staging System (see 
Appendix C). Only 17.3% of HIV positive people had information to classify the stage of 
HIV/AIDS at first diagnosis. Of these 57% were in stage three (late disease). A further 
21% were in stage four (AIDS), while 19.6% were in stage one (asymptomatic/PGL/ 
Acute HIV) and 2.3% were in stage two (early disease). For the rest of the HIV positive 
people (82.7%) no medical conditions were recorded and staging therefore could not be 
done. For example, tests for blood transfusion, pregnancy, insurance and other non-
medical reasons were excluded (see Figure 4.7 & Table 4.10).  
 
4.2.9 International Classification for Diseases 10 (ICD 10) 
When medical conditions of the 17.3% who had information on medical conditions were 
classified according to the ICD10 (see Appendix G), the results suggest that TB is the 
most common opportunistic infection in the Nelson Mandela Metropole. More than a 
third, 34.5%, of HIV positive people suffered from TB, followed by other bacterial 
infections, 17.5%, and other infectious and parasitic infections, 15.2%. Other specified 
diseases accounted for 12.7%, viral infections 9.4%, unspecified diseases 2.4%, 
generalized lymphadenopathy 1.7% and candidiasis 1.4%. Other diseases amount to less 
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than a percentage each. The majority of these individuals suffered from curable parasitic 
or bacterial infections (see Table 4.11 & Appendix G). 
 
4.2.10 Diagnostic year and diagnostic stage 
 
 
Figure 4.8: Diagnostic year (1991-1999) and diagnostic stage of HIV positive   
                      people, NMM 
 
Source: NMM ATICC, 2000 (N=4742)
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The researcher excluded the year 2000 because the data only included cases up to April. 
After 1991 the number of people diagnosed in stage four sharply decreased from 60% to 
31.3% in 1993. Subsequently, there was another sharp decrease in the number of people 
diagnosed in stage four, from 38.1% in 1996 to 17.6% in 1997. Whilst the number of 
HIV positive people diagnosed in stage one sharply increases after 1996, from 6.3% to 
22.7% in 1999. There was a sharp increase in the number of people diagnosed in stage 
three after 1991, from 40% to 68.8% in 1993. Overall, the results indicate that after 1993 
the number of people diagnosed with HIV in stage three and four decreased sharply (see 
Figure 4.8 & Table 4.12).  
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4.3 Cross tabulations 
For all cross tabulations, the age group (0-4 years) were excluded for the analysis because 
this group requires a different diagnostic classification system. Only cases with medical 
symptoms, from which the diagnostic stage could be derived, were included for cross-
tabulation purposes.   
 
4.3.1 Gender and diagnostic stage  
 
Figure 4.9: Gender and diagnostic stage of HIV positive people, NMM 
 
 
Source: NMM ATICC, 2000 (N= 4388)
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A higher proportion of males, 60.0%, compared to females 55.7%, were diagnosed in 
stage three. While more females, 21.2%, compared to males, 16.8%, were diagnosed in 
stage four. More or less the same proportion of females, 20.6% and males 21.3% were 
diagnosed in stage one (see Figure 4.9 & Table 4.13). 
 
The null hypothesis is rejected, which indicates a significant dependence between gender 
and diagnostic stage, (Chi-square = 15.4; p-value = 0.002, < .05). 
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4.3.2 Population group and diagnostic stage  
Blacks, 57.1%, and people of mixed descent, 61.3%, are more likely to go for an HIV test 
when they are in stage three. Moreover, Blacks, 2.2%, as well as people of mixed 
descent, 3.1 %, are least likely to go for an HIV test in stage two (see Table 4.14). 
 
The null hypothesis is not rejected: The results suggest no dependence between racial 
groups (Blacks and people of mixed descent) and diagnostic stage (Chi-square = 4.1; p-
value = 0.246, > .05).  
 
4.3.3 Age and diagnostic stage 
 
Figure 4.10: Diagnostic age and diagnostic stage of HIV positive people, NMM 
 
Source: NMM ATICC, 2000 (N= 4373)
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The researcher excluded people over 74 years because there were not enough cases for 
analysis purposes. The majority of children aged 5 to14 years were diagnosed in stage 
one. Most adults younger than 64 years were diagnosed in stage three. However, for 
people aged 65-74 years old the proportion of people diagnosed in stage three decreased, 
but the proportion diagnosed in stage four, increased (see Figure 4.10 & Table 4.15). 
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Consequently, the null hypothesis is rejected which, indicates a significant dependence 
between age and diagnostic stage at the time of the HIV test, (Chi-square = 144.2; p-
value = 0.000, < .05).  
 
4.3.4 Place of residence 
More than half, 56.4%, of HIV positive individuals who lived in rural areas, and, 54.1%, 
who lived in urban areas, were more likely to be tested in stage three. Just over a quarter, 
24.6%, of people who live in rural areas and less than a quarter, 22.1%, in urban areas 
were diagnosed in stage one. Whereas, 2.5% of people in urban areas, as well as those in 
rural areas, 2.5%, were less likely to be tested in stage two (see Table 4.16). 
 
The null hypothesis is not rejected; There is no dependence between people living in 
urban areas and those residing in rural areas in relation to diagnostic stage at the time of 
the HIV test, (Chi-square = 3.9; p-value = 0.274, >.05). 
 
4.3.5 Diagnostic institution and diagnostic stage  
 
Figure 4.11: Diagnostic institution and diagnostic stage 
          of HIV positive people, NMM 
 
Source: NMM ATICC, 2000 (N= 4770)
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Of the HIV positive people diagnosed in stage one 1.9% were diagnosed at TB hospitals, 
36% at clinics, 19.5% at other institutions and 9.7% at hospitals. Of the HIV positive 
people diagnosed in stage four, 29% were diagnosed at hospitals, 30.9% were diagnosed 
at other institutions, 9.8% were diagnosed at clinics and 2.9% were diagnosed at TB 
hospitals. Almost all HIV positive individuals at TB hospitals, 95.2%, were diagnosed in 
stage three. Just more than half, 51.9%, diagnosed at clinics were in stage three. Of those 
diagnosed at hospitals, 59.1%, were diagnosed in stage three (see Figure 4.11 & Table 
4.17). 
 
In this study, HIV positive individuals diagnosed at clinics are more likely than those 
diagnosed at hospitals, TB hospitals and other institutions to be in stage one (see Table 
4.17). 
 
Therefore, the null hypothesis is rejected: The results indicate a significant dependence 
between diagnostic institutions compared with stage at the time of the HIV test, (chi-
square = 664; p – value = .000, < .05). 
 
4.3.6 Dwelling type and diagnostic stage 
 
Figure 4.12: Dwelling type and diagnostic stage of HIV positive people, NMM 
 
 
Source: NMM ATICC, 2000 (N= 2999)
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The majority of individuals in this study, irrespective of their dwelling type, were tested 
in stage three (see Figure 4.12 & Table 4.18). 
 
Accordingly, the null hypothesis is not rejected: There is no dependence between 
diagnostic stage and the type of dwelling, (Chi-square = 10.2; p – value = 0.115, p >.05).  
 
4.4 Conclusion  
The results obtained from the AIDS Training Information and Counselling Centre 
(ATICC), suggest that the majority of people in this study seek HIV testing when they are 
already in stage three (late disease) and four (AIDS) of the World Health Clinical Staging 
System. HIV mainly affected people in their reproductive years and part of the labour 
force. In contrast males over 65 years were more at risk than females in the same age 
group to be diagnosed with HIV. Also, in this study, HIV had a significant impact on 
infants (less than 1 year old). Moreover, between 1993 and 1995 more people were 
diagnosed with HIV. Subsequent to 1993 the number of people diagnosed in stage three 
and four decreased whilst the number of people diagnosed in stage one increased. 
 
Additionally, the findings suggest that males seek HIV testing earlier than females. 
Moreover, both Blacks and people of mixed descent were most likely to seek HIV testing 
when they were in stage three (late disease). Children were tested earlier than adults. 
Whereas both people living in rural as well as urban areas were more likely to be tested in 
stage three. In addition, clinics diagnosed HIV earlier than hospitals, TB hospitals and 
other diagnostic institutions. Finally, the results suggest no association between dwelling 
type and diagnostic stage.  
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Chapter 5 
Discussion of results 
 
5.1 Introduction 
In this chapter the results obtained from the AIDS Information, Training and Counselling 
Centre (ATICC) are discussed. First, the demographic characteristics of HIV positive 
people in the NMM (Nelson Mandela Metropole) will be described. These characteristics 
include; age and gender composition, population group, mode of HIV transmission, 
diagnostic institution, place of residence, dwelling type and the year the person was 
diagnosed. Then, the discussion will focus on the association between the diagnostic 
stage and the demographic characteristics of HIV positive people. These characteristics 
entails; gender, age, population group, mode of HIV transmission, place of residence, 
dwelling type, diagnostic institution and the year of diagnosis.   
 
5.2 Diagnostic stage  
The results of this study suggest that the majority of HIV positive people whose medical 
symptoms were recorded, were diagnosed in stage three (late disease) and stage four 
(AIDS) of HIV infection. Accordingly, the results support the hypothesis that the 
majority of patients in the NMM seek HIV testing when they were in the advanced stages 
(three or stage four) of HIV infection. Thus, the results show that people in this study 
who were diagnosed already suffered from severe opportunistic infections. They required 
medical care, which could not be provided by primary healthcare facilities.  
 
5.2.1 Tuberculosis  
In addition to the diagnostic stage, the findings in the Nelson Mandela Metropole show 
that more than a third of HIV positive people suffered from TB. Consequently, in this 
study TB is the most common opportunistic infection in people with HIV. This agrees 
with the research of Colebunders (1989:902) who found that TB was the most common 
opportunistic infection in Africa. Colebunders argues that HIV is responsible for a 
substantial increase in the prevalence in TB. The findings of this study also support the 
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research of Ridzon & Mayanaja-Kizza (2001:34) who found that TB is the leading cause 
of deaths in HIV patients in Africa. 
 
Moreover, the results of this study support concerns of Colebunders (1989:902) 
emphasizing the importance of clinically distinguishing an HIV infected person from a 
HIV-seronegative person with TB. Colebunders argues that many patients with 
tuberculosis, regardless of their HIV status, experience weight loss, fever, and cough, 
decreasing the specificity of the WHO case definition in this sub-population. 
Subsequently, this study support concerns of Mugerwa & Ryder (1994:274), that without 
HIV testing, many HIV-seronegative tuberculosis patients will be classified incorrectly as 
having AIDS. So, the results of this study support suggestions by Colebunders 
(1989:902), that all TB patients in Africa be screened for HIV. 
 
5.3 Demographic profile  
5.3.1 Age and gender composition  
Besides the diagnostic stage, the results suggest that people aged 15-49 years are most 
susceptible to HIV. This is consistent with the other studies which suggest that people in 
their reproductive years, which also constitute part of the labour force, are most 
susceptible to HIV(Whiteside and Sunter 2000:58; Dorrington et al. 2004:14; Shisana et 
al. 2005:33-34; DOH 2006:17; UNAIDS 2006:505-506; StatsSA 2006:6). People in their 
reproductive years are more sexually active than the rest of the population. They are more 
at risk, of contracting STI’s and HIV.  
 
Furthermore, the findings of this study indicate that females account for almost two thirds 
of HIV infection in the NMM. Subsequently, the result of this study is consistent with 
other studies which suggest that females between 15-49 years are more at risk of 
contracting HIV than males in the same age group (Whiteside & Sunter 2000:58; 
Dorrington et al. 2004; Shisana et al. 2005; DOH 2006:17; UNAIDS 2006; StatsSA 
2006). Budlender and Johnson (2002:9,26) explain the predominance of female infections 
due to the following reasons: Firstly,  females are biologically more susceptible to 
infections than males; Secondly, females in these regions have lower socio-economic 
 
 
 
 
 51
status with lower employment levels; Thirdly, since females are financially dependent on 
their partners, they are unable to insist on safer sexual practices; Finally, females are also 
vulnerable to sexual violence and sexual abuse.  
 
Also, the results of this study suggest that males over 65 years are more susceptible than 
females in the same age group to contract HIV. A possible explanation is that females in 
this age group are not as sexually active as males in the same age group. Research by 
Dennerstein and colleagues in 2000, showed that sexual functioning of woman decline 
significantly with age and the menopausal transition. As a result of this menopausal 
transition, the relationship with the partner and his ability to perform sexually is 
adversely affected (Dennerstein et al. 2001:459).  
 
Moreover, the results of this study show that HIV is concentrated in the age group 25-29 
years, probably the most sexually active group. The prevalence of HIV in the age group 
0-4 years is most likely the result of mother to child transmission. HIV prevalence in the 
age group 5-9 years is probably the result of rape and may be attributed to the belief that 
sleeping with a virgin is a cure for HIV. The prevalence of HIV in the age group 9-10 
years could also be the result of rape or statutory rape. The findings of this study 
therefore, support arguments by Shell (2000:2) and Marks (2002:21) that cultural factors 
such as the belief that sleeping with a virgin can cure the disease are setting off higher 
infection rates. As a result, rape is increasing and, therefore, there are higher infection 
levels amongst women and children contributing to the spread of the disease (Shell 
2000:2-3).   
 
Thus, the findings of this study suggest that HIV/AIDS mainly affects the people in their 
reproductive years. In particular, females in their reproductive years are more at risk of 
contracting HIV than males in the same age group. Therefore, the findings support 
concerns that AIDS will increase the adult mortality rate for all population groups and 
reduce life expectancy. It will alter the age and gender structure of the population because 
females who are more vulnerable to the disease will die more quickly. Moreover, this will 
affect population growth, as females of childbearing age will die (Mostert et al. 1998:97-
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100, Whiteside 1998:79; Whiteside & Sunter 2000:70-73; Bartos & Piot 2002:209-210; 
Ziehl 2002:67-71; Dorrington et al. 2004:3). The AIDS pandemic will reduce the average 
household income and increase medical expenses as workers become ill and children are 
orphaned this will create an increasing economic and social burden for the government 
(Mostert et al. 1998:97-100, Whiteside 1998:79; Whiteside & Sunter 2000:70-73; Bartos 
& Piot 2002:209-210; Ziehl 2002:67-71; Dorrington et al. 2004:3). Fortunately, studies 
by Dorrington and colleagues in 2006, found that government’s HAART programme 
reduced the impact of HIV/AIDS on mortality (Dorrington & Johnson 2006:563). 
 
However, Adetunju (1998) argues, that HIV estimates and results focus mainly on 
prevalence (absolute number of people infected), prevention and the demographic impact 
of HIV/AIDS. Also, Udjo (2005:90) is concerned that prior to 1994, there was no 
systematic collection of mortality data on a national scale in censuses and surveys in the 
country. Consequently, and with the HIV/AIDS epidemic, estimates of mortality for 
South Africa vary, and often by a large number. Therefore, AIDS statistics should be 
treated with caution.  
 
Despite differences in HIV estimates of previous research, the findings of this study 
support concerns by, Bah (2005:155) that differences in estimates should not distract 
from the fact that HIV has become South Africa’s biggest health problem of the 21st 
century.  
 
5.3.2 Population group  
Besides the age gender profile, the results suggest that HIV infection in the NMM was 
highest in black population, followed by people from mixed descent. HIV infection in 
Indians/Asians and Whites were very low. The findings agreed with the findings of Shell 
(2000:2-3), who found that HIV infection to be highest among Blacks, growing amongst 
people of mixed descent and the lowest amongst Asians and Whites in the city.  
 
 
 
 
 
 53
5.3.3 Mode of HIV transmission  
In addition to the population group, the results indicate that heterosexual infections in the 
NMM, accounted for more than two thirds of HIV infection in the NMM. This study, 
agrees with previous research which suggests that the disease is mainly transmitted 
through heterosexual intercourse, and is currently the most dominant form of infection in 
South Africa. (Sher 1989:46; Williamson et al. 1995:782; Schoub 1999:24; Budlender & 
Johnson 2002:38). Unlike the developed world (Western Europe, North America, 
Australia and New Zealand) where HIV is mostly concentrated in homosexuals and 
bisexual men, and intravenous drug abusers (Sher 1989:46; Williamson et. al. 1995:782; 
Schoub 1999:24; Budlender & Johnson 2002:38).  
 
5.3.4 Place of residence 
The majority of HIV positive people in this study were living in urban areas. This study, 
as with other studies, suggests that HIV prevalence is higher in urban than in rural areas 
(Morris et al. 2000:339; Shell 2000:2-3). Unlike Sub-Saharan countries, where lower 
infection rates in rural areas are the result of immobility and geographic isolation of rural 
communities, South African rural comunities are not as static and geographically isolated 
as that in the rest of Africa (Budlender & Johnson 2002:34). 
 
The migrant labour system might be responsible for this phenomenon. The Eastern Cape 
includes former homelands where the migrant labour system was responsible for men 
working in the cities. Here they would have sex with women other than their wives, 
which is ideal for the spread of sexually transmitted infections. The migrant labour 
system has caused a steady flow of HIV infected men through the rural communities to 
their families in rural communities, and the urban areas where they work (Whiteside & 
Sunter 2000:65; Budlender & Johnson 2002:34). Thus, the results suggest that temporary 
migration even after the end of apartheid continued to assist in the spread of HIV.  
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5.3.5 Dwelling type  
Since socio-economic status was not recorded, the type of dwelling could be a helpful 
indicator of socio-economic status. We expect people with street addresses to be “better 
off” than those without formal housing and, therefore, to have better access to health 
facilities and health benefits. 
 
Yet, the majority of HIV positive people in this study had street addresses. We, therefore, 
expected a lower prevalence, but this is not the case. The results of this study do not 
support previous studies which suggest that HIV mostly affects the most deprived socio-
economic communities with limited antiretroviral therapy (Morris et al. 2000:339).  
The results could therefore not be explained in this study and needs further research. 
 
5.3.6 Diagnostic institution 
Regarding the mode of transmission, the results indicate that almost half of people in this 
study were diagnosed at hospitals. It needs to be considered that hospitals only treat 
patients referred by primary healthcare facilities, such as clinics. The findings therefore 
suggest that the majority of people in this study seek HIV testing, when requiring medical 
attention which could not be provided at primary healthcare facilities such as clinics.  
 
5.3.7 Diagnostic year 
In addition to the dwelling type, the results of this study indicated that between 1993, 
1994 and 1995 the number people diagnosed with HIV almost doubled for each year.  
 
The Jaipur paradigm theory of Whiteside & Sunter (2000:65) is supported that argues that 
the social engineering of apartheid created the ideal environment for the spread of HIV, 
for the following reasons: firstly, the creation of homelands impoverished Blacks, 
especially in the Eastern Cape. Blacks were prevented from bringing their families in to 
urban areas. The homelands provided poor access to health care facilities. Secondly, the 
migrant labour system caused men to move away from their families in the rural areas for 
long periods. Men being away from their wives for such long periods facilitated urban 
prostitution, as they had sex with women other than their wives. They then spread 
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diseases in rural communities which had poor access to health care facilities. Also in 
urban areas, Blacks had poorer access to healthcare facilities, than Whites did. These 
events created the ideal environment for the spread of STI’s and HIV/AIDS. Thirdly, 
rural areas had limited access to healthcare facilities and diagnostic facilities for STI’s 
and HIV/AIDS. As a result, STI’ and HIV/AIDS went either untreated or improperly 
treated (Whiteside & Sunter 2000:65; Marks 2002:18,20). 
 
During 1994, South Africa experienced a major political transformation, from apartheid 
to democracy. Political power was transferred from a white minority to a black majority. 
For the black majority this transition brought an end to what Whiteside & Sunter 
(2000:65) calls, “the fatalism that contributed to the spread of HIV”.  
 
Consequently, the results of this study support Whiteside and Sunter’s theory (2000:65), 
that the “widespread philosophy of fatalism” which diminished individual worth, 
responsibility and accountability, created an ideal situation for the spread of HIV/AIDS.  
People, especially those living in the impoverished homelands, were now free to move to 
urban areas, to seek basic and free healthcare services.  
 
5.3.8 Diagnostic year and diagnostic stage  
Although more people sought HIV testing after 1994, the results also indicated that after 
1993, more people were diagnosed in stage one (asymptomatic/acute HIV/PGL) and less 
people were diagnosed in stage four (AIDS). 
 
As stated in 5.3.6, the demise of apartheid in 1994 gave people, especially those living in 
the homelands, better access to basic and free healthcare facilities. Yet, in 1993 political 
change already seemed inevitable, as CODESA (Conference for a Democratic South 
Africa), was finalised. Two important events took place that year. First, the 
announcement that first non-racial election to be held on 27 April 1994. Second, an 
interim constitution was finalised. The interim constitution guaranteed equal rights and 
access to resources, for all South Africans irrespective of race. These rights included 
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equal and free access to basic healthcare. The interim constitution also divided the 
country in the nine new provinces including the former homelands.  
Thus, 1993 was significant, especially for people living in the Eastern Cape. People from 
former homelands were now free to move to urban areas to seek employment and better 
and free access to basic healthcare. These events might explain earlier diagnosis after 
1993. 
 
5.4 Cross tabulations  
5.4.1 Age and diagnostic stage  
Besides the demographic characteristics, the findings suggested that children in the age 
group 5 to14 were more likely than adults to be tested in stage one (asymptomatic/ acute 
HIV/PGL). This could be an artefact of testing, since children have a weaker immune 
system than adults. Children, because of their weaker immune system are more 
vulnerable to opportunistic infections. Consequently, they show symptoms of HIV earlier 
than adults. They thus attend healthcare facilities more frequently and earlier than adults 
do. Subsequently, children are more likely to be tested earlier than adults. 
 
The results also indicate that people over 65 years old were more likely than children and 
adults 15 to 49 years old, to be tested in stage four (AIDS). Like children, adults over 65 
years have a weaker immune system. But, unlike children, people over 65 years might not 
have the same access to healthcare facilities. So, people over 65 will be diagnosed later 
than children and adults younger than 65 years. The results could suggest disease 
progression for children and people over 65 years is faster, than adults 15 to 49 years old.   
 
Consequently, the results indicate dependence between age and diagnostic stage, (Chi-
square = 144.2; p-value = 0.000, < .05). 
 
The results supported findings of other studies which indicated that age, among other host 
factors, is a major determinant disease progression (Galai & Kalinkovich 1997:2; 
Adetunju 1998:17; Hogg et al. 1994:1120; Mugerwa & Ryder 1994:271; Mehendale et 
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al. 2002:117). Further, the findings could also suggest that disease progression is faster in 
children than in adults (Weiss 1993:1274; Anderson 2003:39).  
 
5.4.2 Gender and diagnostic stage   
The results indicated that more males than females were tested in stage three (late 
disease), whilst more females than males were tested in stage four (AIDS). A possible 
explanation for this tendency is the inequality between males and females.  
 
 The findings indicated a dependence between males and females in relation to the 
diagnostic stage, (Chi square = 15.4; p-value = 0.002, < 0.5). 
 
Whiteside and Sunter (2000:65) argued that the apartheid regime’s migrant labour system 
has disempowered, especially black females. Sexually active males migrated in large 
numbers to urban areas, to live in single sex hostels. They were prevented from bringing 
their families into the cities.  
 
In these single sex hostels black men were able to exert power over women who were in 
town illegally and dependent on men for a bed (Ramphele 2000:114; Marks 2002:21). 
Poorer women with fewer financial resources were forced into sexual relationships to 
ensure the survival of themselves and their children (Whiteside & Sunter 2000:65). As a 
result, females became financially dependent on their partners. Females have lower socio 
economic status with lower employment levels than males (Budlender & Johnson 
2002:9,26). Consequently, the migrant labour disempowered women and children (Marks 
2002:18). 
 
Since males had higher employment levels and higher socio-economic status than 
females, they had the advantage of better and earlier access to healthcare, especially 
privatised medical facilities.  
 
In addition, a study by Medley et al. (2004:4) showed that HIV positive females in 
developing countries who disclose their status, ran the risks of being blamed, abandoned, 
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to lose economic support, faced physical and emotional abuse and discrimination which 
led to disruption of family and relationships. Therefore, it is possible that females 
especially those who are financially dependent on males, would postpone HIV testing, as 
long as possible. 
 
5.4.3 Population group and diagnostic stage 
Moreover, the findings indicated that the majority of Blacks as well as people of mixed 
descent, sought HIV testing when they are in stage three (late disease) of HIV/AIDS.  
The results suggest no dependence between Blacks and people of mixed descent when 
compared with diagnostic stage, (Chi-square = 4.1; p-value = 0.246, > .05). 
 
Blacks were worst affected by the apartheid policy. In the Eastern Cape, black people 
were forced into crowded, impoverished homelands, which led to the breakdown of 
traditional cultural structures (Whiteside & Sunter 2000:65; Marks 2002:18). The 
apartheid system through legislation and formalization discriminated against Blacks in 
terms of education and jobs (Whiteside & Sunter 2000:65).  
 
However, people of mixed descent were given preference above Blacks in terms of 
employment and education. As a result, the socio-economic conditions of people of 
mixed descent were better than that of Blacks. Consequently, the majority of people of 
mixed decent had, and still have, better access to health care facilities than Blacks. 
Accordingly, one would expect people of mixed descent to be better informed about 
HIV/AIDS, and would therefore be aware of the importance and benefits of early HIV 
testing. However, this is not the case and some other phenomenon other than education 
and socio-economic status could be responsible. Unfortunately, a socio-economic status 
measurement was not included in the data. Therefore, the association between socio-
economic status in relation to HIV testing could not be established in this study and needs 
further investigation. 
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5.4.4 Place of residence and diagnostic stage 
Since, people in urban areas had better access to health care facilities, one would expect 
that they would seek HIV testing earlier than people who lived in rural areas. Yet, the 
results suggest otherwise.  
 
There is no dependence between people living in urban areas and those residing in rural 
areas in relation to diagnostic stage, (Chi-square = 3.9; p- value = 0.274, >.05).  
 
As stated in 5.3.4, Budlender and Johnson (2002:3) argued that, rural communities in 
South Africa were not as static and geographically isolated as those in the rest of Sub-
Saharan Africa. Additionally, the migrant labour system caused a steady flow of HIV 
infected men through rural communities (Whiteside & Sunter 2000:65; Budlender & 
Johnson 2002:34).  
 
Yet, the demise of apartheid did end ‘temporary’ migration. Posel (2003:16,17) provided 
evidence that the migrant labour system continued until 1999. This research also found 
that people still migrated ‘temporarily’, retaining membership in, and ties with their 
households of origin. Moreover, research by the Southern African Migration Project in 
2004, provided evidence that migration is an important factor in the spread of HIV in 
Southern Africa (Lurie 2004:23).  
 
As a result, continuous interaction between rural and urban communities, might have kept 
rural communities well informed about life in urban areas. For this reason, rural 
communities could be just as aware of HIV/AIDS as urban communities.  
 
In addition, when temporary migrants became infected or sick with HIV/AIDS they 
would still depend on rural family members for care. Thus, sick family members 
returning to rural areas might create the same awareness of HIV/AIDS in rural areas as in 
urban areas. This phenomenon could inspire HIV testing by family members of 
temporary migrants, in rural communities.  
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5.4.5 Diagnostic institution and diagnostic stage  
The results suggested that clinics were more likely than hospitals, TB hospitals and other 
institutions to diagnose HIV/AIDS, in stage one (asymptomatic/acute HIV/PGL). The 
results indicate a dependence between diagnostic institutions compared with stage at the 
time of the HIV test, (Chi-square = 664; p – value = 0.000, < .05). 
 
These findings indicate that clinics identified HIV positive people earlier than all the 
other institutions. Hospitals, TB hospitals and other institutions diagnosed those who are 
already symptomatic. Given that clinics only provide primary health care, the findings 
suggest that people diagnosed at hospitals and TB hospitals suffered from opportunistic 
infections that could not be treated at clinics. They were therefore referred to hospitals, 
TB hospitals or other institutions.  
 
Further, almost all HIV positive people diagnosed at TB hospitals were already in stage 
three (late disease). These findings again support suggestions that all TB patients be 
screened for HIV (Colebunders et al. 1989:902). 
 
5.4.6 Dwelling type and diagnostic stage 
Since socio-economic status was not recorded in this data, the type of dwelling could be a 
helpful indicator of socio-economic status. It was expected that people with street 
addresses would be “better off” than people without formal housing (informal 
settlements/ sites with services/locations). They possibly also had better access to health 
facilities and healthcare benefits. For that reason, one expects a lower prevalence and 
earlier testing among people with formal housing. Yet, the results suggest the opposite. 
 
The results suggest no dependence between dwelling type and diagnostic state, (Chi-
square = 10.2; p – value = 0.115, >.05). 
 
 
 
 
 
 
 
 61
Consequently, this study does support previous research, which suggested that HIV-1 
subtype C is mostly found in inner city populations. The results of this study does not  
agree  with research by Morris et al. (2000:339) which suggested that HIV mostly 
affected the most deprived socio-economic communities with limited antiretroviral 
therapy. 
 
5.5 Conclusion 
In conclusion, the results obtained from HIV positive individuals in the Nelson Mandela 
Metropole, suggest that the majority sought HIV testing when they were already in the 
advanced stages three (late disease) and four (AIDS) of HIV infection. HIV mainly 
affected part of the labour force and people in their reproductive years. Females in their 
reproductive years were more at risk than males in the same age group to contract HIV. 
However, males over 65 years of age were more at risk than females in the same age 
group to contract HIV. Also, HIV/AIDS had an impact on infants (<1 years). Moreover, 
between 1993 and 1995 more people were diagnosed with HIV. Also, after 1993 the 
number of people diagnosed in stage three and four decreased, but the number of people 
diagnosed in stage one increased.  
 
Additionally, the findings suggest that males sought HIV testing earlier than females. 
Furthermore, both Blacks and people of mixed descent were most likely to seek HIV 
testing when they were in stage three (late disease). Moreover, children are tested earlier 
than adults. Whereas, both people living in rural as well as urban areas were more likely 
to be tested in stage three. Further, clinics diagnosed HIV earlier than hospitals, TB 
hospitals and other diagnostic institutions. Finally, there was no association between 
diagnostic stage and dwelling type. 
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Chapter 6 
Conclusion 
 
 
The purpose of this study was to test whether, the majority of patients in the Nelson 
Mandela Metropole, i.e. Port Elizabeth as it was formerly known, sought HIV-testing 
when they were already in stages three (late disease) and four (AIDS) of HIV infection 
(see Appendix C). 
 
The following null hypotheses were investigated: 
H01: There is no significant difference between males and females with regard to 
the diagnostic stage at the time of the HIV test. 
H02: There is no significant difference between population groups in relation to 
the diagnostic stage. 
H03: No significant difference exists between age groups with regard to the 
diagnostic stage. 
H04: There is no difference regarding the type of dwelling relating to the stage at 
the time of HIV testing. 
H05: No significant difference exists between place of residence and the diagnostic 
stage. 
H06: The diagnostic institute is not significant in relation to the stage at the time of 
HIV testing.  
 
The research presented in this thesis supports the hypothesis that people in the Region A 
health district, NMM seek HIV testing only when they were stages three (late disease) 
and four (AIDS) of HIV infection. Thus, for the majority of these individuals anti-
retroviral therapy had come too late and they were, thus waiting to die. 
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The findings also indicate that males in the NMM, sought HIV testing earlier than 
females. Moreover, Blacks and people of mixed descent were most likely to sought HIV 
testing when they were in stage three (late disease). Also, clinics diagnosed HIV earlier 
than hospitals, TB hospitals and other institutions. The results also suggested that 
children were diagnosed earlier than adults. Between 1993 and 1995, more people were 
diagnosed with HIV. Subsequent to 1993, the number of people diagnosed in stage three 
and four decreased significantly, but the number of people diagnosed in stage one 
increased.  
 
 The results are similar with other findings which suggest that HIV is mainly transmitted 
through heterosexual infections. The findings are also consistent with previous 
researchers which suggested that females in their reproductive years are more susceptible 
to HIV. In particular, females in this study account for more than two thirds of HIV 
infection. In addition, HIV mostly affects part of the labour force and people in their 
reproductive years. The findings also support theories which suggest that the social 
engineering of apartheid was conducive for the spread of HIV/AIDS.  
 
Contrary to previous research the results of this study indicate that HIV did not only 
affect the most deprived socio-economic areas. Finally, unlike previous research the 
findings of this study suggest that HIV was more prevalent in urban than rural areas. 
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Policy afterword  
This study has provided better insight into the lack of information concerning the 
incubation period of HIV positive individuals. This project has also provided a detailed 
analysis of the disease progression based on new data on AIDS-related conditions and 
opportunistic infections in the Eastern Cape, which could facilitate the clinical diagnosis 
of HIV. 
 
In particular, this study aims to encourage health and welfare policies in South Africa 
aimed at early voluntary testing, counselling services as well as timeous anti-retroviral 
treatment for HIV positive individuals. Voluntary counselling and testing empower 
clients to use their test results to reduce the risk of HIV transmission and to make 
informed decisions about important life events such as partner selection, marriage, 
pregnancy and family finances (Marum et al. 2001:527). Early testing is important 
because implemented with HAART (Highly Active Antiretroviral Therapy) it increases 
life expectancy and the quality of life of HIV-positive individuals. Furthermore, a clinical 
definition of HIV will also facilitate in the diagnosis of individuals who avoid HIV-
testing because of the fear of needles, the attached stigma and ignorance about the 
disease.  
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Limitations  
This study, like other studies in Africa, is based on individuals with unknown dates of 
seroconversion (Morgan & Withworth 2001:143). Therefore this study cannot predict the 
median survival time from seroconversion to death. Also, this is not a representative 
sample and therefore we cannot generalize for whole population. In addition more 
females were recorded in this study which could skew the results to reflect higher 
prevalence among females. Still, we can obtain valuable information on opportunistic 
infections and the incubation period of HIV/AIDS. For some unknown reason, a large 
proportion of data for the mode of transmission, dwelling type and place of residence was 
not recorded. This could have distorted the results.  
 
If we understand the level of difference between demographic attributes (age, gender, 
population group, mode of HIV transmission, dwelling type, diagnostic institution, and 
diagnostic year), yet we do not understand what cause these differences. Further research 
is important to understand why these differences occur.  
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Appendix A 
 
 
World Health Organization /Bangui Clinical AIDS Case Definition for Use in 
Africa: 1985 
• Major signs  
o Weight loss > 10% body weight  
o Chronic diarrhea > 1 month  
o Prolonged fever > 1 month (intermittent or constant) 
• Minor signs  
o Persistent cough > 1 month  
o Generalized pruritic dermatitis  
o Recurrent herpes zoster  
o Oropharyngeal candidiasis  
o Chronic progressive and disseminated herpes simplex infection 
Source 
HIV InSite Knowledge Base Chapter 
Published June 1998 
Dennis H. Osmond, PhD, University of California San Francisco 
http://hivinsite.ucsf.edu/InSite?page=kb-01-01  
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Appendix B 
 
 
Summary of 1986 CDC Classification System for HIV Infection 
 
Group I. Acute infection 
Group II. Asymptomatic infectiona 
Group III. Persistent generalized lymphadenopathya 
Group IV. Other disease 
     Subgroup A. Constitutional disease 
     Subgroup B. Neurologic disease 
     Subgroup C. Secondary infectious diseases 
          Category C-1. Specified secondary infectious diseases listed in the CDC 
surveillance definition for AIDSb 
          Category C-2. Other specified secondary infectious diseasesc 
     Subgroup D. Secondary cancersb 
     Subgroup E. Other conditions 
 
a Patients in Groups II and III may be sub-classified on the basis of a laboratory 
evaluation. 
b Includes those patients whose clinical presentation fulfils the 1987 definition of AIDS 
used by the CDC for national reporting. 
c Conditions described under Category B in the 1993 classification system. 
 
   
  
 
Source 
HIV InSite Knowledge Base Chapter 
Published June 1998 
Dennis H. Osmond, PhD, University of California San Francisco 
http://hivinsite.ucsf.edu/InSite?page=kb-01-01  
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Appendix C 
World Health Organization Classification System for HIV Infection: 1989 
Clinical Stage 1 
1.  Asymptomatic infection 
2.  Persistent generalized lymphadenopathy 
3.  Acute retroviral infection 
 Performance Stage 1:  asymptomatic, normal activity  
 
Clinical Stage 2 
4.  Unintentional weight loss < 10% body weight 
5.  Minor mucocutaneous manifestations (e.g., dermatitis, prurigo, fungal nail infections, 
angular cheilitis) 
6.  Herpes zoster within previous 5 years 
7.  Recurrent upper respiratory tract infections 
 Performance Stage 2:  symptoms, but nearly fully ambulatory 
 
Clinical Stage 3 
8.  Unintentional weight loss > 10% body weight 
9.  Chronic diarrhea > 1 month 
10.  Prolonged fever > 1 month (constant or intermittent) 
11.  Oral candidiasis 
12.  Oral hairy leukoplakia 
13.  Pulmonary tuberculosis within the previous year 
14.  Severe bacterial infections 
15.  Vulvovaginal candidiasis 
 Performance Stage 3: in bed more than normal but < 50% of normal daytime during the 
previous month  
 
Clinical Stage 4 
16.  HIV wasting syndrome 
17.  Pneumocystis carinii pneumonia 
18.  Toxoplasmosis of the brain 
19.  Crytosporidiosis with diarrhea > 1 month 
20.  Isosporiasis with diarrhea > 1 month 
21.  Cryptococcosis, extrapulmonary 
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22.  Cytomegalovirus disease of an organ other than liver, spleen or lymph node 
23.  Herpes simplex virus infection, mucocutaneous 
24.  Progressive multifocal leukoencephalopathy 
25.  Any disseminated endemic mycosis (e.g., histoplasmosis) 
26.  Candidiasis of the esophagus, trachea, bronchi, or lung 
27.  Atypical mycobacteriosis, disseminated 
28.  Non-typhoid Salmonella septicemia 
29.  Extrapulmonary tuberculosis 
30.  Lymphoma 
31.  Kaposi's sarcoma 
32.  HIV encephalopathy 
 Performance Stage 4:  in bed > 50% of normal daytime during previous month   
 
Source 
HIV InSite Knowledge Base Chapter 
Published June 1998 
Dennis H. Osmond, PhD, University of California San Francisco 
http://hivinsite.ucsf.edu/InSite?page=kb-01-01  
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Appendix D 
 
Revised Caracas Definition: 1991 
The revised "Caracas" AIDS definition requires a positive HIV serology, the absence of 
cancer or other cause of immunosuppression, plus greater than or equal to 10 cumulative 
points, as follows: 
Kaposi's sarcoma (10 points) 
Extrapulmonary/non-cavitary pulmonary tuberculosis (10) 
Oral candidiasis or hairy leukoplakia (5) 
Cavitary pulmonary/unspecified tuberculosis (5) 
 Herpes zoster less than 60 years of age (5) 
 CNS dysfunction (5) 
Diarrhoea greater than or equal to 1 month (2) 
Fever greater than or equal to 1 month (2) 
Cachexia or greater than 10% weight loss (2) 
Asthenia greater than or equal to 1 month (2) 
Persistent dermatitis (2) 
Anemia, lymphopenia, or thrombocytopenia (2) 
Persistent cough or any pneumonia except TB (2) 
Lymphadenopathy greater than or equal to 1 cm greater than or equal to 2 non-inguinal 
sites greater than or equal to 1 month (2) 
For the Brazilian patients from which it was derived, sensitivity is 95% and specificity 
100% (91% without HIV serology), compared to 59% and 98%, respectively, for the 
WHO clinical definition. 
 
Source 
http://www.aegis.com/conferences/07wac/WC96.html 
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Appendix E 
 
The revised CDC classification system for HIV-infected adolescents and 
adults: 1993 
 
Criteria for HIV infection for persons ages greater than 13 years: a) repeatedly reactive 
screening tests for HIV antibody (e.g., enzyme immunoassay) with specific antibody 
identified by the use of supplemental tests (e.g., Western blot, immunofluorescence 
assay); b) direct identification of virus in host tissues by virus isolation; c) HIV antigen 
detection; or d) a positive result on any other highly specific licensed test for HIV.  
CD4+ T-Lymphocyte Categories  
The three CD4+ T-lymphocyte categories are defined as follows:  
Category 1: greater than or equal to 500 cells/mL  
Category 2: 200-499 cells/uL  
Category 3: less than 200 cells/uL 
These categories correspond to CD4+ T-lymphocyte counts per microliter of blood and 
guide clinical and therapeutic actions in the management of HIV-infected adolescents and 
adults (22-28). The revised HIV classification system also allows for the use of the 
percentage of CD4+ T-cells (Appendix A).  
HIV-infected persons should be classified based on existing guidelines for the medical 
management of HIV-infected persons (22). Thus, the lowest accurate, but not necessarily 
the most recent, CD4+ T-lymphocyte count should be used for classification purposes.  
 
Clinical Categories  
The clinical categories of HIV infection are defined as follows: 
 
Category A  
Category A consists of one or more of the conditions listed below in an adolescent or 
adult (greater than or equal to 13 years) with documented HIV infection. Conditions 
listed in Categories B and C must not have occurred. 
Asymptomatic HIV infection  
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Persistent generalized lymphadenopathy  
Acute (primary) HIV infection with accompanying illness or history of acute HIV 
infection (29,30) 
 
Category B  
Category B consists of symptomatic conditions in an HIV-infected adolescent or adult 
that are not included among conditions listed in clinical Category C and that meet at least 
one of the following criteria: a) the conditions are attributed to HIV infection or are 
indicative of a defect in cell-mediated immunity; or b) the conditions are considered by 
physicians to have a clinical course or to require management that is complicated by HIV 
infection. Examples of conditions in clinical Category B include, but are not limited to: 
Bacillary angiomatosis  
Candidiasis, oropharyngeal (thrush)  
Candidiasis, vulvovaginal; persistent, frequent, or poorly responsive to therapy  
Cervical dysplasia (moderate or severe)/cervical carcinoma in situ  
Constitutional symptoms, such as fever (38.5 C) or diarrhea lasting greater than 1 month 
Hairy leukoplakia, oral  
Herpes zoster (shingles), involving at least two distinct episodes or more than one 
dermatome 
Idiopathic thrombocytopenic purpura  
Listeriosis  
Pelvic inflammatory disease, particularly if complicated by tubo-ovarian abscess 
Peripheral neuropathy  
For classification purposes, Category B conditions take precedence over those in 
Category A. For example, someone previously treated for oral or persistent vaginal 
candidiasis (and who has not developed a Category C disease) but who is now 
asymptomatic should be classified in clinical Category B.  
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Category C  
Category C includes the clinical conditions listed in the AIDS surveillance case definition 
(Appendix B). For classification purposes, once a Category C condition has occurred, the 
person will remain in Category C. 
 
Source 
www.hivinsite.ucsf.edu/InSite?=kb-01-01 
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Source 
Appendix F 
 
 
Revised WHO Case Definition for AIDS in Africa (Abidjan Conference): 1991 
“ AIDS Wasting Definition” 
 
AIDS in an adult is defined by a positive HIV test and one of the following (in the absence 
of a condition unrelated to HIV infection that may cause the sign/diagnosis):  
1. Weight loss > 10% or cachexia, with diarrhea or both, intermittent or constant, for > 
1 month  
2. Tuberculosis with weight loss > 10%, or disseminated, miliary, or extrapulmonary 
tuberculosis  
3. Kaposis's sarcoma  
4. Neurologic impairment preventing independent daily activities  
5. Esophageal candidiasis 
   
 
HIV InSite Knowledge Base Chapter 
Published June 1998 
Dennis H. Osmond, PhD, University of California San Francisco 
http://hivinsite.ucsf.edu/InSite?page=kb-01-01  
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Appendix G 
 
WHO International Classification for Diseases 10 
Human immunodeficiency virus [HIV] disease (B20-B24) 
Note:  
The fourth-character subcategories of B20-B23 are provided for optional use where it 
is not possible or not desired to use multiple coding to identify the specific conditions.  
Excludes:  
asymptomatic human immunodeficiency virus [HIV] infection status ( Z21 )  
 
B20 Human immunodeficiency virus [HIV] disease resulting in infectious and 
parasitic diseases  
Excludes: Acute HIV infection syndrome (B23.0 )  
B20.0 HIV disease resulting in mycobacterial infection  
HIV disease resulting in tuberculosis 
B20.1 HIV disease resulting in other bacterial infections  
Abscess 
Bedsores  
Boils 
Broncho-pneumonia 
Bubo 
Cystitis  
Carbuncle 
Cellulitis 
Impetigo 
Lesions, genital, skin 
Pneumonia 
Sepsis  
Septicaemia 
Tonsillitis 
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B20.2 HIV disease resulting in cytomegalovirus disease  
(disease of organ other than liver spleen or lymph node?) 
B20.3 HIV disease resulting in other viral infections  
Gastroenteritis 
Hepatitis 
Hepato renal problems 
Herpes simplex virus 
Herpes zoster 
Retrovirus 
Rubella  
Thyroid fever 
Ulcer tongue, genital, peptic, mouth 
Warts 
B20.4 HIV disease resulting in candidiasis  
Candidiasis 
Oral candidiasis 
Vulva-vaginal candidiasis 
B20.5 HIV disease resulting in other mycoses  
Cryptococcal  
Renal failure 
Renal functional problem 
Urinary tract infection 
B20.6 HIV disease resulting in  
Pneumocystis carinii pneumonia  
B20.7 HIV disease resulting in multiple infections  
Multiple disease 
B20.8 HIV disease resulting in other infectious and parasitic diseases  
Scabies 
Malaria 
Jaundice  
Ringworm/dermatophyte 
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B20.9 HIV disease resulting in unspecified infectious or parasitic disease 
(HIV disease resulting in infection NOS) 
Infection 
Skin infection 
Sores (tongue, mouth, ears, buttocks, face etc.) 
Sexually transmitted infections  
B21 Human immunodeficiency virus [HIV] disease resulting in malignant 
neoplasms  
B21.0 HIV disease resulting in Kaposi's sarcoma  
B21.1 HIV disease resulting in Burkitt's lymphoma  
B21.2 HIV disease resulting in other types of non-Hodgkin's lymphoma  
B21.3 HIV disease resulting in other malignant neoplasms of lymphoid, 
hematopoietic and related tissue  
Leukemia 
Lymphoma  
B21.7 HIV disease resulting in multiple malignant neoplasms  
Tumors 
B21.8 HIV disease resulting in other malignant neoplasms  
Cervix cancer 
Cervical cancer 
Rectal cancer 
B21.9 HIV disease resulting in unspecified malignant neoplasm  
Malignancies 
B22 Human immunodeficiency virus [HIV] disease resulting in other specified 
diseases 
B22.0 HIV disease resulting in encephalopathy  
Confusion 
Dementia  
Meningitis 
Psychosis  
B22.1 HIV disease resulting in lymphoid interstitial pneumonitis  
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B22.2 HIV disease resulting in wasting syndrome  
Wasting Syndrome 
B22.7 HIV disease resulting in multiple diseases classified elsewhere  
For use of this category, reference should be made to the morbidity or mortality coding 
rules and guidelines in Volume 2.  
B23 Human immunodeficiency virus [HIV] disease resulting in other conditions  
B23.0 Acute HIV infection syndrome  
Back ache 
Head ache  
Influenza 
Malaise  
Palpitation 
B23.1 HIV disease resulting in (persistent) generalized lymphadenopathy  
Lymphadenopathy 
PGL 
B23.2 HIV disease resulting in hematological and immunological abnormalities, not 
elsewhere classified  
Bleeding 
Blood in stool 
Epistaxis 
Haemorrhagia 
Hemorrhoids 
Menorrhagia 
Pancytopenia 
Uremia 
B23.8 HIV disease resulting in other specified conditions  
Ascites 
Asthma 
Bells’ palsy 
Bronchitis 
Cachexia 
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Capillus 
Cardio pulmonary 
Chronic cough 
Chronic pain 
Cirrhosis 
Dysphasia 
Epilepsy 
Heart failure 
Hemoptysis 
Malnutrition 
Mastitis 
Organ failure 
Rashes  
Swellings 
Pericardial effusion 
Pharyngitis 
Pelvic inflammatory disease 
Pleurale effusion 
Pyelonephritis 
Respiratory arrest 
Stroke 
Sudden death 
Vomiting 
Weakness  
Weight loss 
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Source 
 http://www3.who.int/icd/vol1htm2003/fr-icd.htm 
 
 
 
B24 Unspecified human immunodeficiency virus [HIV] disease 
Acquired immunodeficiency syndrome [AIDS] NOS  
AIDS-related complex [ARC] NOS  
Bowel obstruction 
Loss of appetite 
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Appendix H 
Diagnostic Clinical Staging System for HIV positive people in the Nelson 
Mandela Metropole 
 
Clinical Stage 1: Asymptomatic /acute HIV/PGL 
Medical name  Condition  
Acute Retroviral  Infection  Resemble flu, or other viral syndromes. 
Anemia  a reduction in the quantity of oxygen-carrying 
pigment hemoglobin in the blood 
Cachexia Weakness 
Malaise  A vague feeling of discomfort  
Fever Elevation of body temperature above the normal 37 C 
Headache  Pain in the head 
Night Sweats  
Influenza   An acute viral infection of the respiratory tract 
Palpitation an awareness of heartbeat 
Persistent Generalized 
Lymphadenopathy 
Lymph nodes are larger than one centimeter in 
diameter, in two or more other sites other than the 
groin area for a period of at least three months.  
Not HIV related diseases Staged because person was asymptomatic 
Arthritis  inflammation of the joints 
Ascites  Effusion and accumulation of serious fluid in the 
abdominal cavity 
Asthma  Recurrent attack of paroxysmal  dyspnoea 
Bleeding  Escape of blood as from an injured vessel  
Bowel Obstruction Unspecified 
Diabetes Unpredictable fluctuations of blood glucose values 
and difficult to control 
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Epilepsy 
 
 
Paroxysmal disturbances of brain function that may 
be manifested as episodic impairment or loss of 
consciousness 
Hepatitis  Inflammation of the liver 
Hypertension Persistently  high arterial blood pressure 
Malnutrition Any disorder of nutrition  
Loss of appetite  
Mastitis Inflammation of breast  
Menorrhagia Heavy bleeding at menstruation 
Metabolic Disorder  Unspecified  
STI’s  Unspecified Sexually transmitted diseases  
Thyroid Fever  Fever pertaining to thyroid gland 
Warts Hyperplasic epidermal lesion caused by Human 
Papillomavirus  
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Clinical Stage 2: Early (mild) disease  
Cutaneous infections Skin infections  
 Rash Eruption of the skin 
Sores Any lesion of the skin  
Other diseases  
Bell’s Palsy Facial nerve palsy 
Dehydration Excessive loss of body water 
Hemorrhage piles  
Peritonitis  Inflammation of the peritoneum (membrane lining  
the walls of abdominal cavity) 
Tonsillitis  Inflammation of tonsils due to bacterial or viral 
infection 
Cellulites  An infection in the deep dermis of the skin  
Chronic pains in joins Pain requiring medical attention  
Uremia  An excess of nitrogenous and products of protein and 
amino acid metabolism in the blood 
Abdominal pains  Unspecified  
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Clinical Stage 3: Late disease 
Viral infections  
Gastroenteritis Inflammation of the stomach and intestine  
Herpes Zoster shingles rash, viral inflammation of the central 
nervous system, presenting with localized pain and 
burning sensations, followed by vesicle eruption 
(skin blistering) and ulceration 
Severe bacterial infections  
Bubo  Enlarged inflamed lymph node 
Conjunctivitis Inflammation of the membrane that covers the eye 
Lesions Any pathological  or traumatic discontinuity of tissue 
or loss of function of  a part  
Pneumonia  Inflammation of the lungs, caused by bacteria  
Sepsis  Presence of pathogenic micro organisms or their 
toxins in the blood; systemic disease 
Respiratory infections or 
illnesses  
 
Bronchitis  Inflammation of the bronchi  
Chronic couch  Cough required medical attention 
Mycosis  Any disease caused by fungi 
Pulmonary Tuberculosis An infectious disease of the lungs caused by bacillus 
mycobacterium   
Renal failure/Dysfunction Unspecified  
Parasitic infections  
Tinea Ringworm, a parasitic fungus upon the skin  
Fungal infections    
Candidiasis Thrush (infection  by fungi most commonly 
involving skin, oral mucosa, vagina or respiratory 
tract 
Fungi Unspecified 
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Other HIV related disease Staged because patients was HIV positive 
Chronic illness Unspecified 
Liver problems Unspecified  
Diarrhoea chronic  Abnormally frequent discharge of semi-fluid or fluid 
faecale matter from the bowel  
Swellings Abnormal enlargement of a body part or area not due 
to cell proliferation  
Capillus  Unspecified hair disorder 
Myositis  Muscle disease  
Weight loss decrease in body weight that is not voluntary 
Pancytopenia  Abnormal depression of all the cellular elements of 
the blood 
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Clinical Stage 4: Severe disease, AIDS 
AIDS Patient was diagnosed with full blown AIDS, disease 
not specified  
Bacterial infections  
Abscess A localized collection of pus anywhere in body 
surrounded and walled off by damaged tissue. 
Boils multiple  
 
Bronco-pneumonia  Inflammation of the lungs 
Bedsores Debicutis ulcer                                                                
Carbuncle  A collection of boils  
Cystitis Inflammation of urinary bladder  
Impetigo Bacterial infection of skin 
Septicaemiae  Blood poisoning 
Viral infections   
Herpes simplex An inflammatory skin disease marked by the 
formation of small vesicles in clusters  
Herpes zoster multiple  
 
Rubella Mild viral infection marked by a pink macular rash, 
fever and lymph nodes 
Retrovirus unspecified  Large of RNA viruses that include leukoviruses and 
lentiviruses  
Hepato renal problems decreased urine production 
Ulcers A break in the skin extending to all its layers  
Mycosis  disease caused by fungi 
Cryptococcus Fungal infection 
Urinary tract infection 
 
Malignancies  diseases tending to worsen and end up in death  
Leukemia  A progressive  malignant disease of blood-forming 
organs 
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Cervical cancer Cancer of the cervix  
Lymphoma  A malignant tumor of the lymph nodes 
Kaposi sarcoma  A malignant tumor on the skin, reddish brown or 
purplish plagues or nodules on the skin and mucous 
membranes  
Tumors A new growth of tissue 
Non-Hodgkins lymphoma Presence of large tumor  
Candidiasis Thrush, infection by fungi , most commonly 
involving skin, oral, vagina or respiratory tract 
Oesophageale candidiasis Candidiasis of the gullet  
Oral candidiasis  Candidiasis of the mouth  
Vulvo-Vaginal Candidiasis Vulvo-vaginal Candidiasis: candidiasis of the vulva 
and vagina   
Central nervous system 
dysfunction  
Dysfunctions of central nervous system  
Encephalopathy  Any degenerative brain disease 
Confusion  Disturbed orientation in regard to time, place or 
person, sometimes accompanied by disordered 
consciousness  
Syncope  Mental disorder that feature loss of contact with 
reality 
Meningitis  Inflammation of the tissue membranes of the brain 
Dementia  Chronic persistent disorder of behaviour and higher 
intellectual function  
Psychosis  Mental disorder that feature loss of contact with 
reality 
Cerebrum Unspecified problems relating to the cerebrum 
Mental disorder  Unspecified 
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Parasitic infections   
Scabies An infection caused by mite   
Jaundice yellowing of the skin and whites of eyes  
Unspecified blood disorders   
Blood formation Unspecified  
Blood Disease  Unspecified  
Respiratory infections   
Dysphasia  Difficulty in swallowing  
Dyspnea Difficulty breathing  
Fissure  Groove or cleft, unspecified  
Hemoptysis Coughing up blood  
Pharyngitis  inflammation in the part of the throat behind the soft 
palate (paharynx) 
Respiratory arrest  Breeding stopped or slowed 
Heart disorders and diseases   
Myocardia  Unspecified  
Myocarditis  Inflammation of the muscular walls of the heart 
Pericarditis  Heart disease  
Organ failure   
Heart failure  Unspecified  
Lung failure  Unspecified 
Organ dysfunction  Unspecified 
Liver dysfunction  Unspecified 
Lung dysfunction  Unspecified 
Wasting syndrome  Gradual loss or decay, losing body weight 
Pelvic inflammatory disease  Acute or chronic infection in the uterus, fallopian 
tubes and ovaries 
Stroke Sudden attack of weakness o one side of the body 
STI’s resistant  STI’s resistant to drugs  
Urinary tract infection An infection that can happen anywhere along the 
urinary tract - the kidneys, the ureters, the bladder 
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Appendix I: List of tables 
 
Table 4.1a: Age and gender composition of HIV positive people 
         Nelson Mandela Metropole (NMM)  
 
 
 
 Diagnostic age * Gender Crosstabulation 
 
Gender 
  Male Female Total 
Count 1073 1350 2423 0-4 
% of Total 3.9% 4.9% 8.9% 
Count 34 56 90 5-9 
% of Total 
.1% .2% .3% 
Count 14 80 94 10-14 
% of Total 
.1% .3% .3% 
Count 203 1752 1955 15-19 
% of Total 
.7% 6.4% 7.2% 
Count 1157 3846 5003 20-24 
% of Total 4.2% 14.1% 18.3% 
Count 2561 4373 6934 25-29 
% of Total 9.4% 16.0% 25.4% 
Count 1765 2677 4442 30-34 
% of Total 6.5% 9.8% 16.3% 
Count 1348 1698 3046 35-39 
% of Total 4.9% 6.2% 11.1% 
Count 835 821 1656 40-44 
% of Total 3.1% 3.0% 6.1% 
Count 435 433 868 45-49 
% of Total 1.6% 1.6% 3.2% 
Count 226 207 433 50-54 
% of Total 
.8% .8% 1.6% 
Count 107 109 216 55-59 
% of Total 
.4% .4% .8% 
Count 55 42 97 60--64 
% of Total 
.2% .2% .4% 
Count 24 23 47 65-69 
% of Total 
.1% .1% .2% 
Count 9 7 16 
Diagnostic 
age 
70-74 
% of Total 
.0% .0% .1% 
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Count 6 5 11 75-79 
% of Total 
.0% .0% .0% 
Count 2 0 2 80-84 
% of Total 
.0% .0% .0% 
Count 0 1 1 85-89 
% of Total 
.0% .0% .0% 
Count 1 0 1 90-94 
% of Total 
.0% .0% .0% 
Count 9855 17480 27335 Total 
% of Total 36.1% 63.9% 100.0% 
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Table 4.1b: Age and gender composition of HIV positive people, <1 years (NMM)  
 
 
 
 Diagnostic Age  *Gender of patient Crosstabulation 
 
Sex of patient 
  Male Female Total 
Count 823 1102 1925 <1 
% of Total 3.0% 4.0% 7.0% 
Count 255 257 512 1-4 
% of Total 
.9% .9% 1.9% 
Count 29 47 76 5-9 
% of Total 
.1% .2% .3% 
Count 14 80 94 10-14 
% of Total 
.1% .3% .3% 
Count 203 1752 1955 15-19 
% of Total 
.7% 6.4% 7.2% 
Count 1157 3846 5003 20-24 
% of Total 4.2% 14.1% 18.3% 
Count 2561 4373 6934 25-29 
% of Total 9.4% 16.0% 25.4% 
Count 1765 2677 4442 30-34 
% of Total 6.5% 9.8% 16.3% 
Count 1348 1698 3046 35-39 
% of Total 4.9% 6.2% 11.1% 
Count 835 821 1656 40-44 
% of Total 3.1% 3.0% 6.1% 
Count 435 433 868 45-49 
% of Total 1.6% 1.6% 3.2% 
Count 226 207 433 50-54 
% of Total 
.8% .8% 1.6% 
Count 107 109 216 55-59 
% of Total 
.4% .4% .8% 
Count 55 42 97 60-64 
% of Total 
.2% .2% .4% 
Count 24 23 47 65-69 
% of Total 
.1% .1% .2% 
Count 9 7 16 70-74 
% of Total 
.0% .0% .1% 
Diagnostic 
Age 
75-79 Count 6 5 11 
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% of Total 
.0% .0% .0% 
Count 3 1 4 80+ 
% of Total 
.0% .0% .0% 
Count 9855 17480 27335 Total 
% of Total 36.1% 63.9% 100.0% 
 
 
 
 
Table 4.2: Gender of HIV positive people, NMM 
 
 Gender 
 
  Frequency Percent Valid Percent 
Cumulative 
Percent 
Female 17491 63.6 64.0 64.0 
Male 9855 35.8 36.0 100.0 
Valid 
Total 27346 99.4 100.0   
 Missing 159 .6     
Total 27505 100.0     
 
 
Table 4.3: Diagnostic age; mean median and mode 
Statistics
Age of patient*
27482
23
27.2311
28.0000
29.00
11.90290
22.0000
28.0000
34.0000
Valid
Missing
N
Mean
Median
Mode
Std. Deviation
25
50
75
Percentiles
 
 
 
 
 
 106 
Table 4.4.a: Population group of NMM, 1996 census 
 
 Population group of head of household (Q5) 
 
  Frequency Percent Valid Percent Cumulative Percent 
Black 55294 52.1 52.7 52.7 
Mixed 30335 28.6 28.9 81.6 
Indian/Asian 914 .9 .9 82.5 
White 18373 17.3 17.5 100.0 
Valid 
Total 104916 98.9 100.0   
  Missing 1146 1.1     
Total 106062 100.0     
 
 
Table 4.4.b: Population group of HIV positive people, NMM 
 Population group 
 
  Frequency Percent Valid Percent 
Cumulative 
Percent 
Black 25465 92.6 92.7 92.7 
Mixed 1801 6.5 6.6 99.2 
White 199 .7 .7 100.0 
Indian/Asian 10 .0 .0 100.0 
Valid 
Total 27475 99.9 100.0   
 Missing 30 .1     
Total 27505 100.0     
 
 
Table 4.5: Mode of HIV transmission, NMM 
 
How was HIV transmitted
18348 66.7 91.5 91.5
80 .3 .4 91.9
1627 5.9 8.1 100.0
20055 72.9 100.0
7450 27.1
27505 100.0
Heterosexuals
Other transmission
Mother to child
transmission
Total
Valid
Missing
Total
Frequency Percent Valid Percent
Cumulative
Percent
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Table 4.6: Institution where HIV was diagnosed, NMM 
 
 
 
 
 
Table 4.7: Place of residence of  HIV positive people, NMM 
 
 Region Type 
 
  Frequency Percent Valid Percent 
Cumulative 
Percent 
Urban area 12704 46.2 85.6 85.6 
Rural area 1745 6.3 11.8 97.3 
Other 395 1.4 2.7 100.0 
Valid 
Total 14844 54.0 100.0   
 Missing 12661 46.0     
Total 27505 100.0     
 
 
 
Diagnostic Institution
15599 56.7 56.8 56.8
7118 25.9 25.9 82.7
2330 8.5 8.5 91.2
1053 3.8 3.8 95.1
366 1.3 1.3 96.4
335 1.2 1.2 97.6
225 .8 .8 98.4
178 .6 .6 99.1
129 .5 .5 99.6
67 .2 .2 99.8
43 .2 .2 100.0
12 .0 .0 100.0
27455 99.8 100.0
50 .2
27505 100.0
Hospital 
Clinic 
Doctor 
Insurance
Eastern Cape Blood
Transfusion Services 
Prison 
TB Hospital 
Military Hospital 
District Surgeon
Pre-employment
Industry 
Academic
Total 
Valid
Missing
 
 
Total 
Frequency Percent Valid Percent
Cumulative 
Percent
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Table 4.8: Dwelling type in which HIV positive people lives, NMM 
 Dwelling
7720 28.1 66.4 66.4
2576 9.4 22.2 88.6
368 1.3 3.2 91.7
273 1.0 2.3 94.1
185 .7 1.6 95.7
155 .6 1.3 97.0
83 .3 .7 97.7
59 .2 .5 98.2
54 .2 .5 98.7
39 .1 .3 99.0
38 .1 .3 99.4
19 .1 .2 99.5
17 .1 .1 99.7
16 .1 .1 99.8
15 .1 .1 99.9
4 .0 .0 100.0
2 .0 .0 100.0
11623 42.3 100.0
15882 57.7
27505 100.0
Street  Address
Site and Service
Prison
Hostel
Barracks
Informal Settlement
Location
Flat
Business
Farm
P.O. Box
Sports Fac
Hospice
Care of
Academic
Hotel
Harbour
Total
Valid
Missing
Total
Frequency Percent Valid Percent
Cumulative
Percent
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Table 4.9: Year HIV was diagnosed, NMM 
 
Year of diagnosis
190 .7 .7 .7
430 1.6 1.6 2.4
749 2.8 2.8 5.2
1232 4.7 4.7 9.9
2494 9.5 9.5 19.4
3706 14.1 14.1 33.5
5238 19.9 19.9 53.4
5818 22.1 22.1 75.5
6446 24.5 24.5 100.0
26303 100.0 100.0
1991
1992
1993
1994
1995
1996
1997
1998
1999
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
 
 
 
Table 4.10: Diagnostic stage of HIV positive people, NMM 
In which stage was the patient when tested
937 3.4 19.6 19.6
111 .4 2.3 22.0
2721 9.9 57.0 79.0
1003 3.6 21.0 100.0
4772 17.3 100.0
22733 82.7
27505 100.0
Clinical Stage 1
Clinical Stage 2
Clinical Stage 3
Clinical Stage 4
Total
Valid
Missing
Total
Frequency Percent Valid Percent
Cumulative
Percent
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Table 4.11: International Classification for Diseases 10 
International Classification for Diseases 10
8 .2 .2 .2
1647 34.5 34.5 34.7
837 17.5 17.5 52.2
1 .0 .0 52.2
447 9.4 9.4 61.6
69 1.4 1.4 63.1
40 .8 .8 63.9
9 .2 .2 64.1
2 .0 .0 64.1
726 15.2 15.2 79.3
43 .9 .9 80.2
7 .1 .1 80.4
1 .0 .0 80.4
9 .2 .2 80.6
4 .1 .1 80.7
5 .1 .1 80.8
42 .9 .9 81.7
8 .2 .2 81.8
38 .8 .8 82.6
80 1.7 1.7 84.3
28 .6 .6 84.9
605 12.7 12.7 97.6
116 2.4 2.4 100.0
4772 100.0 100.0
 
Tuberculosis
Other Bacterial Infections
Cytomegaloviral Disease
Other Viral Infections
Candidiasis
Other Mycoses
Pneumocystis carinii
pneumonia
Multiple Infections
Other infectious or
Parasitic Diseases
Unspecified Infectious and
Parisitic Diseases
Kapis's sarcoma
Non-Hodgkin's Lymphoma
Malign. Neoplasms-
lymphoid, haematopoietic,
related tissue
Other Malignant
Neoplasms
Unspecified Malignant
Neoplasms
Encephalopathy
Wasting Syndrome
Acute HIV infection
Syndrome
Persistent Generalized
Lymphadenopathy
Haematological and
Imunological
abnormalities, not class.
Other specified conditions
Unspecified HIV disease
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Table 4.12: Diagnostic year and diagnostic stage of HIV positive people, NMM 
 
 Year of diagnosis * In which stage was the patient when tested  Crosstabulation 
 
 
  In which stage was the patient when tested Total 
  
Clinical 
Stage 1 
Clinical 
Stage 2 
Clinical 
Stage 3 
Clinical 
Stage 4   
Year of 
diagnosis 
1991 Count 0 0 2 3 5 
    % within Year of 
diagnosis .0% .0% 40.0% 60.0% 100.0% 
  1992 Count 0 0 9 7 16 
    % within Year of 
diagnosis .0% .0% 56.3% 43.8% 100.0% 
  1993 Count 0 0 11 5 16 
    % within Year of 
diagnosis .0% .0% 68.8% 31.3% 100.0% 
  1994 Count 2 1 28 18 49 
    % within Year of 
diagnosis 4.1% 2.0% 57.1% 36.7% 100.0% 
  1995 Count 3 0 52 34 89 
    % within Year of 
diagnosis 3.4% .0% 58.4% 38.2% 100.0% 
  1996 Count 17 1 149 103 270 
    % within Year of 
diagnosis 6.3% .4% 55.2% 38.1% 100.0% 
  1997 Count 268 33 763 227 1291 
    % within Year of 
diagnosis 20.8% 2.6% 59.1% 17.6% 100.0% 
  1998 Count 325 42 923 299 1589 
    % within Year of 
diagnosis 20.5% 2.6% 58.1% 18.8% 100.0% 
  1999 Count 322 34 769 292 1417 
    % within Year of 
diagnosis 22.7% 2.4% 54.3% 20.6% 100.0% 
Total Count 937 111 2706 988 4742 
  % within Year of 
diagnosis 19.8% 2.3% 57.1% 20.8% 100.0% 
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Table 4.13: Gender and diagnostic stage of HIV positive people, NMM 
 
Gender* In which stage was the patient when tested  Crosstabulation
567 69 1536 585 2757
574.9 62.8 1579.6 539.7 2757.0
20.6% 2.5% 55.7% 21.2% 100.0%
348 31 978 274 1631
340.1 37.2 934.4 319.3 1631.0
21.3% 1.9% 60.0% 16.8% 100.0%
915 100 2514 859 4388
915.0 100.0 2514.0 859.0 4388.0
20.9% 2.3% 57.3% 19.6% 100.0%
Count
Expected Count
% within Sex of patient
Count
Expected Count
% within Sex of patient
Count
Expected Count
% within Sex of patient
Female
Male
Gender
Total
Clinical
Stage 1
Clinical
Stage 2
Clinical
Stage 3
Clinical
Stage 4
In which stage was the patient when tested
Total
 
 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 15.376(a) 3 .002 
Continuity Correction 
      
Likelihood Ratio 15.624 3 .001 
Linear-by-Linear 
Association 2.963 1 .085 
N of Valid Cases 4388     
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Table 4.14: Population group and diagnostic stage of HIV positive people, NMM 
 
 
 
 
 
 
 
Chi-Square Tests 
4.145a 3 .246
4.290 3 .232
1.954 1 .162
4393
Pearson Chi-Square 
Continuity Correction 
Likelihood Ratio 
Linear-by-Linear 
Association
N of Valid Cases 
Value df
Asymp. Sig. 
(2-sided) 
 
. 
 
Population group * In which stage was the patient when tested  Crosstabulation
36 7 138 44 225
47.1 5.1 128.9 43.9 225.0
16.0% 3.1% 61.3% 19.6% 100.0%
883 93 2379 813 4168 
871.9 94.9 2388.1 813.1 4168.0
21.2% 2.2% 57.1% 19.5% 100.0%
919 100 2517 857 4393 
919.0 100.0 2517.0 857.0 4393.0
20.9% 2.3% 57.3% 19.5% 100.0%
Count
Expected Count
% within Population group
Count
Expected Count
% within Population group
Count
Expected Count
% within Population group
Mixed 
Black
Population 
group
Total 
Clinical 
Stage 1
Clinical 
Stage 2
Clinical 
Stage 3
Clinical 
Stage 4 
In which stage was the patient when tested
Total 
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Table 4.15: Diagnostic age and diagnostic stage of HIV positive people, NMM 
 
 Diagnostic age * In which stage was the patient when tested  Crosstabulation 
 
In which stage was the patient when tested 
  
Clinical 
Stage 1 
Clinical 
Stage 2 
Clinical 
Stage 3 
Clinical 
Stage 4 Total 
Count 9 0 4 3 16 
Expected Count 3.4 .4 9.2 3.1 16.0 
5-14 
% within Diagnostic age 56.3% .0% 25.0% 18.8% 100.0% 
Count 328 22 521 165 1036 
Expected Count 217.7 23.5 593.0 201.8 1036.0 
15-24 
% within Diagnostic age 31.7% 2.1% 50.3% 15.9% 100.0% 
Count 407 56 1143 395 2001 
Expected Count 420.5 45.3 1145.3 389.9 2001.0 
25-34 
% within Diagnostic age 20.3% 2.8% 57.1% 19.7% 100.0% 
Count 139 16 599 207 961 
Expected Count 202.0 21.8 550.1 187.2 961.0 
35-44 
% within Diagnostic age 14.5% 1.7% 62.3% 21.5% 100.0% 
Count 27 4 193 64 288 
Expected Count 60.5 6.5 164.8 56.1 288.0 
45-54 
% within Diagnostic age 9.4% 1.4% 67.0% 22.2% 100.0% 
Count 9 1 43 18 71 
Expected Count 14.9 1.6 40.6 13.8 71.0 
Diagnostic 
age 
55-64 
% within Diagnostic age 12.7% 1.4% 60.6% 25.4% 100.0% 
Count 919 99 2503 852 4373 
Expected Count 919.0 99.0 2503.0 852.0 4373.0 
Total 
% within Diagnostic age 21.0% 2.3% 57.2% 19.5% 100.0% 
 
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 144.196(a) 15 .000 
Continuity Correction 
      
Likelihood Ratio 142.863 15 .000 
Linear-by-Linear 
Association 107.735 1 .000 
N of Valid Cases 4373     
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Table 4.16: Place of residence and diagnostic stage of HIV positive people, NMM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chi-Square Tests 
3.889a 3 .274
4.073 3 .254
2.412 1 .120
3248
Pearson Chi-Square 
Continuity Correction 
Likelihood Ratio 
Linear-by-Linear 
Association
N of Valid Cases 
Value df
Asymp. Sig. 
(2-sided) 
 
. 
Place of residence* In which stage was the patient when tested  Crosstabulation
69 7 158 46 280
62.5 6.9 152.2 58.4 280.0
24.6% 2.5% 56.4% 16.4% 100.0%
656 73 1607 632 2968
662.5 73.1 1612.8 619.6 2968.0
22.1% 2.5% 54.1% 21.3% 100.0%
725 80 1765 678 3248
725.0 80.0 1765.0 678.0 3248.0
22.3% 2.5% 54.3% 20.9% 100.0%
Count
Expected Count
% within Region Type 
Count
Expected Count
% within Region Type 
Count
Expected Count
% within Region Type 
Rural area 
Urban area 
Region
Type
Total 
Clinical 
Stage 1
Clinical 
Stage 2 
Clinical 
Stage 3
Clinical 
Stage 4
In which stage was the patient when tested
Total 
F 
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Table 4.17: Diagnostic institution and diagnostic stage of HIV positive people, 
NMM 
 
Diagnostic Institution * In which stage was the patient when tested  Crosstabulation
2 0 99 3 104
20.7 2.4 58.9 22.0 104.0
1.9% .0% 95.2% 2.9% 100.0%
660 43 950 179 1832
365.2 42.2 1037.7 386.8 1832.0
36.0% 2.3% 51.9% 9.8% 100.0%
29 9 65 46 149
29.7 3.4 84.4 31.5 149.0
19.5% 6.0% 43.6% 30.9% 100.0%
260 58 1588 779 2685
535.3 61.9 1520.9 566.8 2685.0
9.7% 2.2% 59.1% 29.0% 100.0%
951 110 2702 1007 4770
951.0 110.0 2702.0 1007.0 4770.0
19.9% 2.3% 56.6% 21.1% 100.0%
Count
Expected Count
% within Diagnostic
Institution
Count
Expected Count
% within Diagnostic
Institution
Count
Expected Count
% within Diagnostic
Institution
Count
Expected Count
% within Diagnostic
Institution
Count
Expected Count
% within Diagnostic
Institution
TB Hospital
Clinic
Other
Hospital
Diagnostic
Institution
Total
Clinical
Stage 1
Clinical
Stage 2
Clinical
Stage 3
Clinical
Stage 4
In which stage was the patient when tested
Total
 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 664.292(a) 9 .000 
Continuity Correction 
      
Likelihood Ratio 686.566 9 .000 
Linear-by-Linear Association 
      
N of Valid Cases 4770     
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Table 4.18: Dwelling type and diagnostic institution of HIV positive people, NMM 
 
 Dwelling type * In which stage was the patient when tested  Crosstabulation
414 56 1150 495 2115
441.5 55.0 1134.7 483.8 2115.0
19.6% 2.6% 54.4% 23.4% 100.0%
441.5 17 389 164 757
158.0 19.7 406.1 173.2 757.0
24.7% 2.2% 51.4% 21.7% 100.0%
25 5 70 27 127
26.5 3.3 68.1 29.1 127.0
19.7% 3.9% 55.1% 21.3% 100.0%
626 78 1609 686 2999
626.0 78.0 1609.0 686.0 2999.0
20.9% 2.6% 53.7% 22.9% 100.0%
Count
Expected Count
% within 
Dwelling type
Count
Expected Count
% within 
Dwelling type
Count
Expected Count
% within 
Dwelling type
Count
Expected Count
% within 
Dwelling type
Street  Address
Location/Informal
settlements/Sites
with services
Prison/Hostels/
Barracks
 Dwelling
type
Total
Clinical
Stage 1
Clinical
Stage 2
Clinical
Stage 3
Clinical
Stage 4
In which stage was the patient when
tested
Total
 
 
 
 
  
 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 10.239(a) 6 .115 
Continuity Correction 
      
Likelihood Ratio 9.896 6 .129 
Linear-by-Linear 
Association 4.501 1 .034 
N of Valid Cases 2999     
 
 
 
 
 
 
